Author: admin

  • Improvement in unhealthy behaviors among patients with chronic kidney

    Improvement in unhealthy behaviors among patients with chronic kidney

    Introduction

    Chronic kidney disease (CKD) is a common communicable disease affecting over 850 million people worldwide.1 It is a major cause of morbidity and mortality, and its prevalence is increasing globally.2 The cost of kidney replacement therapy is very high, posing a big threat to economic status in every country, especially in low- and middle-income countries. The expenditure on kidney replacement therapy (KRT) accounts for 0.91 to 7.1% of national healthcare budget.3 However, most developing countries do not have public funding support for the cost of KRT.4 Patients with CKD usually have shorter longevity and lower quality of life than controlled population.5 Thus, providing effective means for early recognition and treatment to delay kidney disease progression is of prime importance. Besides specific pharmacologic intervention, lifestyle modification is an indispensable part for delaying kidney disease progression.6 These include control of body weight, exercise, avoidance of tobacco and analgesic use, and control of dietary protein and salt intake. However, in real world practice, the patient’s compliance with this recommendation is still far from perfect. Among patients with diabetes, there were only 53.5% of cases who were able to achieve satisfactory body mass index (BMI).7 Only 25% to 50% of CKD patients could comply with dietary intake recommendation.8

    Herbal, alternative, and supplementary therapies are commonly used by CKD patients, despite potential risks and limited evidence of efficacy.9 This is particularly true among Asian patients due to a common belief that natural products are healing remedies which should be harmless to the body.10–12 Use of herbal medicines was as high as 42.65% of Thai patients with CKD.13,14 Since detailed compositions of many medical herbs are unknown or not clearly identified, continuing consumption of herbal medicines poses a continuing risk factor of CKD progression.15,16

    Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recognized as a risk factor for CKD progression.17 Despite this adverse effect, use of NSAID or other analgesics for pain relief is not uncommon among CKD patients. About 27% of CKD patients in a Canadian population-based study received at least one NSAID prescription.18 In Thailand, NSAIDs or analgesic use was found in 39% of CKD patients living in the rural area.19

    A randomized controlled trial (RCT), the ESCORT-1 study, was conducted to evaluate the effectiveness of an integrated care approach for CKD patients at the community level.20 In that study, patients with stage 3 or 4 CKD residing in a rural district of Kamphaengphet Province, approximately 400 kilometers north of Bangkok, Thailand, received multidisciplinary care at the district hospital and home visits conducted by community nurses from sub-district health offices in collaboration with village health volunteers. It was observed that patients assigned to the intervention group exhibited a reduced rate of kidney disease progression compared to those in the control group, who received conventional care. Furthermore, the intervention group consistently adhered to a low-salt, low-protein diet regimen throughout the study period. It could be inferred that such comprehensive care would empower patients in the intervention group to make more significant lifestyle modifications.

    The ESCORT-2 Study was subsequently expanded to include five district hospitals. The care program was modified to be less strict and more aligned with the realities of community-level care in Thailand. Nevertheless, core care activities were maintained.21 Interventions included training healthcare personnel in CKD management, employing multidisciplinary care teams, conducting scheduled patient education during hospital visits, and implementing regular home visits with protocol checklists by sub-district community nurses and village health volunteers. After a 3-year observation period, the ESCORT-2 Study demonstrated a significantly lower rate of kidney disease progression among its participants when compared to the control group of the preceding ESCORT-1 Study.21 Given that adverse lifestyle factors can accelerate the progression of CKD, it is important to determine if an integrated care approach can improve these unhealthy behaviors. Thereafter, in planning the ESCORT-2 Study, we determined to prospectively and systematically monitor a set of unhealthy behaviors as well as clinical and biochemical parameters throughout the course of the study period. This study is a follow-up part of the ESCORT-2 study, which has already been published, but will focus on the change in unhealthy behaviors along the course of that study.

    Materials and Methods

    This article presents a post-hoc analysis of the ESCORT-2 Study data to examine the effect of an integrated care model on modifying unhealthy behaviors associated with CKD progression. The protocol of ESCORT-2 Study was approved by the Ethics Committee of Institutional Review Board, Ministry of Public Health, Thailand, and registered with www.clinicaltrials.in.th (TCTR-20160614001). It was conducted in accordance with the ethical principles of the Declaration of Helsinki. All study participants provided informed consent before the initiation of the study. It was a 3-year prospective cohort study.21 Those who were 18–70 years old and had estimated glomerular filtration rate(eGFR) of 15–59 mL/ min/ 1.73 m2 body surface area (BSA) was enrolled. eGFR was calculated by using the 2009 CKD-EPI formula. Details of the exclusion criteria and methods of study have been described elsewhere.21 In brief, the integrated care program consisted of a hospital-based multidisciplinary care team (HMDT) at each district hospital, and a home-based community care network team (CCNT) at each sub-district health office. HMDT is comprised of 1–2 general practitioners, a CKD nurse practitioner, 1–2 pharmacists, a nutritionist, and a physical therapist. During patients’ hospital visit every 3 months, enrolled cases were interviewed about their current unhealthy behaviors. HMDT provides group education and clinical care to patients. The education included basic knowledge on and self-care for CKD; avoidance of high-salt and high-protein diet; avoidance of use of alcohol, tobacco, herbal medicines, and over-the-counter analgesics or NSAIDs; and advice on regular exercise. The cases were interviewed on their history of the use of herbal medicines, analgesics, or NSAIDs. The CCNT, comprised of a community nurse working at each sub-district health center, and village health volunteers (VHVs) who were responsible for caring for the cases residing in that village, conducted the interviews. CCNT gave advice during home visit every 6 months to the cases on how to conduct healthy behavior to delay CKD progression. CNNT also assessed exercise practicing at home, and consumption of salty or high-protein foods. Antihypertensive agents such as angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) available at the public primary healthcare level were enalapril and losartan, respectively. Antihyperglycemic agents available for use were sulfonylurea, metformin, and insulin.

    The body mass index was defined as actual weight in kg standardized to a square meter of body height. It was measured at baseline and every 12 months thereafter. An herb was defined as any medicinal product with ingredients made from one or more kinds of plants. Herbal or analgesic/NSAIDs use was defined, on a yes/no basis, as a history of using any herb or analgesic/NSAIDs once during each 3-month period. The term “NSAIDs use” was used exclusively only when a specific drug can be identified as an NSAID. In Thailand, the use of NSAIDs is often linked to the use of pre-packaged, over-the-counter painkiller drugs.22 Therefore, when collecting patient history, a broad term like “analgesic use” was applied to capture all potential NSAID exposure.

    CCNT conducted home visits every 6 months, during which each patient was interviewed about their exercise frequency and salty food consumption in the past week. Exercise could be in the form of either cardiovascular, strengthening or stretching type. Due to the difficulty in distinguishing between authentic exercise and daily agricultural work, lack of exercise at home was defined as having one or fewer authentic exercise sessions in the past week.

    Consumption of high salt intake was obtained by using a standard food interview form (SFIF). It was designed by Department of Health Service Support, Ministry of Public Health, Thailand [Appendix 1] and had routinely been used by community nurses during their field works. In that form, 10 types of commonly consumed salty foods or food condiments were listed. During the home visit by CCNT, each patient was interviewed to figure out the frequency of salty food items consumed in a week preceding the home visit. The amount of daily protein intake (DPI) was assessed with a short protein food recall questionnaire (S-PFRQ) developed by a renal dietitian for this study [Appendix 2]. It was counted as the number of tablespoons of high-protein food items consumed during the preceding week and was expressed as a daily average. We have previously reported that DPI estimated from S-PFRQ correlated well with the protein-equivalent of total nitrogen appearance, which was calculated from 24-hour urinary urea-nitrogen excretion.23

    Outcomes

    Continuous variables are presented as mean ± SD, while categorical data are presented as percentages. CKD was stratified into stages 3A, 3B, and 4 based on eGFR values. Usage of herbs and analgesic or NSAIDs obtained during each hospital visit were pooled together over a 12-month interval. If a patient reported such usage once or more at 12-month period, it would be scored as “having unhealthy behavior”. Prevalences of overweight were assessed at baseline and annually thereafter. Participants with BMI of 23 kg/m2 or higher were labeled as being overweight. Lack of regular exercise, salt, and protein intake were assessed at baseline and during home visits every six months. Participants were labeled as having unhealthy behaviors if they reported any of these behaviors during any home visit in a given year. Participants whose unhealthy behaviors were observed in over 50% of recorded instances were classified as having persistent unhealthy behaviors. The cumulative prevalence of unhealthy behaviors was determined for each participant at baseline and annually. Each identified unhealthy behavior was assigned a value of 1 point. The impact of this cumulative unhealthy behavior score on the progression of CKD was analyzed. Although changes in blood pressure and proteinuria could affect the rate of progression of kidney disease, the results of these changes had already been reported in the previous study22 and will not be presented herein. Comparison between baseline and annual prevalence of each unhealthy behavior was made with McNemar’s chi-square test, The influence of the persistent unhealthy behavior on CKD progression was examined by comparing eGFR decline rates between the persistent and non-persistent groups using an independent t-test. Statistical analyses were using the SPSS program software version 23. Statistical analysis was regarded as significant when the p-value was < 0.05.

    Results

    Out of 1211 cases with CKD stages 3–4, aged 18–70 years-old who were screened for enrollment in the ESCORT-2 Study, fifty-two cases declined the study, 297 cases were excluded, leaving 914 cases for enrollment.22 The mean age was 62 + 6 years, and 67% were female (Table 1). About 80% of the case received primary education (up to grade 6 from the grade 1–12 scale). Hypertension, hyperlipidemia and diabetes were found in 92%, 68% and 53%, respectively. About 60% of the cases had overweight, defined as BMI equal to or more than 23.0 Kg/m2 which is the cut-off limit of overweight for Asian population.24 At enrollment, the histories of herbal medicine usage, analgesic usage and smoking were 23%, 35% and 36%, respectively.

    Table 1 Demographic and Clinical Characteristics of Study Participants at Baseline

    The cases were stratified at baseline by stages of CKD and types of unhealthy behavior (Table 2), there was no significant difference among the CKD stages with respect to the proportion of cases with usage of herbal medicine or analgesic, moderate to high salt intake, and high protein intake. However, the prevalence of NSAID use, being overweight, and lack of exercise were significantly less observed in cases with stage 4 CKD than those in the earlier stages of CKD (P =0.001, P = 0.006, and P = 0.006, respectively).

    Table 2 The Prevalence of Unhealthy Behaviors Among Study Participants Stratified by Stage of CKD at Baseline, No. of Cases (%)

    Table 3 illustrated trends of change of unhealthy behaviors along the course of the study. Usage of herbal medicine declined from 23.3% of cases at baseline to 13.4% at the 1st year of follow-up (difference = −9.77, 95% CI [−13 to −6.5]), to 7% at the 2nd year of follow-up (−15, 95% CI [−18 to −12]), and to 5% at the 3rd year of follow-up (−17, 95% CI [−21 to −14]), P < 0.0001 for all comparisons.

    Table 3 Percentage of Unhealthy Behaviors at Baseline and From the First year to Third year of Follow up

    The prevalence of analgesic or NSAID usage decreased remarkably from 34.9% and 4.3%, respectively, at baseline to 18.6% and 2.6%, respectively, at the 1st year (P < 0.0001 and P < 0.036, respectively), to 16.0% and 2.0%, respectively, at the 2nd year (P < 0.0001 and P < 0.005, respectively), and to 7.8% and 1.3%, respectively, at the 3rd year (P < 0.0001 for both).

    The percentage of overweight participants exceeded 60% throughout the study period and did not decrease with integrated care management (Table 3). Using the standard food interview form (SFIF), the baseline prevalence of moderate to high salt intake was 22.1%, which significantly decreased to 18% at the one-year follow-up (P=0.0021). Further reductions were observed at the two-year (12.9%) and three-year (14.1%) follow-ups (P<0.0001). In contrast, the prevalence of high protein intake, as estimated by the S-PFRQ, did not change significantly during the study.

    The potential for unhealthy behaviors to exacerbate the progression of CKD has been suggested.25 This study aimed to determine if the sustained accumulation of unhealthy behaviors over time correlated with a greater rate of decline in eGFR. We conducted a comparative analysis of eGFR decline between participants exhibiting persistent unhealthy behaviors and those without [Table 4]. However, the results did not reveal any statistically significant differences in eGFR decline between the two groups for any of the unhealthy behaviors investigated.

    Table 4 Relationship Between Persistent Unhealthy Behaviors and Rate of eGFR Decline

    Nevertheless, we observed a progressive decline in the percentage of participants with unhealthy behavior counts of 3 or more, from 26% at baseline to 17%, 14.8%, and 14.4% at years 1, 2, and 3, respectively, during the follow-up period (Figure 1). Furthermore, participants with unhealthy behavior counts of 3 or more at baseline exhibited a significantly faster rate of eGFR decline compared to those with fewer than 3 unhealthy behaviors (−2.04 vs −1.02 mL/min per 1.73 m² per year; mean difference 0.98 [95% confidence interval (CI) 0.48–1.48], P < 0.001) (Figure 2).

    Figure 1 Trend of cumulative unhealthy behavior scores. UH count less than 3; UH count equal or more than 3.

    Abbreviation: UH, Unhealthy behavior.

    Figure 2 Comparison of extrapolation lines represent eGFR decline rate between participants with UH count less than 3 and UH count equal or more than 3. UH count less than 3; UH count equal or more than 3.

    Abbreviations: UH, Unhealthy behavior; eGFR, estimated Glomerular filtration rate.

    Discussion

    Previous literature has shown that several unhealthy behaviors can negatively impact the progression of CKD, particularly during its early stages.25 Clinical practice guidelines for CKD management emphasize the crucial role of lifestyle modifications as a fundamental component of treatment.6 However, these changes can be difficult for patients to comply with due to various factors including low health literacy, inadequate education programs, and lack of motivation. Therefore, effective CKD management strategies should prioritize patient support and education to facilitate the adoption of healthier behaviors.

    The previous ESCORT-1 and ESCORT-2 studies utilized an integrated care approach that combined lifestyle modification into the clinical management of CKD patients.21,22 This concerted approach involved a HMDT during hospital consultations and a CCNT during home visits. Each team member had a specific set of activities to provide for the patient during each visit. The activities were rotated throughout the year to maintain patient engagement with the advice. The core educational content, however, remained focused on basic CKD knowledge and lifestyle modifications to slow disease progression. The integrated care model incorporated several behavioral change techniques. Regular interviews and home visits provided opportunities for feedback and monitoring. Group education sessions offered instruction on healthy behaviors. Live demonstrations illustrate these behaviors, while home visits facilitated social support.26 In the end, there was a reduced rate of CKD progression among participants in the intervention group who received integrated care. Nevertheless, the extent to which this model effectively modified unhealthy behaviors, and the precise nature of these changes requires further investigation.

    Participants who were enrolled in the ESCORT-2 Study were living in rural communities of a province in northern Thailand. They could be representative of typical Thai rural population. This communication addresses seven unhealthy behaviors known to contribute to CKD progression. These behaviors fall into three categories: 1. Medication use-related unhealthy behaviors (usage of analgesics or NSAIDs, and herbal medicine); 2. Unhealthy dietary behaviors (consumption of food items containing moderate to high salt content, and high protein content); and 3. Lifestyle-related behaviors (lack of exercise, and obesity). The baseline prevalence rates of these unhealthy behaviors were largely consistent with those reported in previous studies.25 However, it is noteworthy that the prevalence of being overweight and the use of analgesics or NSAIDs were notably high, reaching 60% and 40%, respectively. In our study, the prevalence of NSAIDs use alone appeared to be lower than what has been reported for the general population in previous studies.27 This is because the inclusion of both analgesic and NSAIDs terminology was utilized to ensure a comprehensive capture of all possible exposures to NSAIDs. In Thai rural areas, people often get NSAIDs from pre-packaged analgesic drugs sold in local pharmacies or grocery stores. If we combine the prevalence of analgesic and NSAIDs use described herein, the overall prevalence becomes higher than what has been previously reported for the general Thai population but is comparable to a previous report of 39% among CKD patients in a rural area of another part of Thailand.19 This could be attributed to the fact that the population enrolled in this study consisted primarily of agricultural workers engaged in physically demanding jobs. Moreover, the widespread availability of over-the-counter pain-relieving packages containing multiple analgesics and NSAIDs in village-level stores could have facilitated easy access to potentially harmful medications for CKD patients.

    The prevalences of these unhealthy behaviors at baseline were analyzed separately for each stage of CKD. A lower prevalence of overweight, NSAID utilization, and physical inactivity was observed among patients with CKD stage 4 when compared to stages 3A and 3B. It is plausible that individuals in this advanced stage of the disease had a heightened understanding of their condition’s seriousness, leading to improved compliance with recommended healthy behaviors.

    The present study provides compelling evidence of a substantial decrease in several critical unhealthy behaviors throughout the study duration. Although the improvement of unhealthy behaviors demonstrated variability across different categories, the findings of our study indicate a marked and consistent decrease in medication-usage related unhealthy behaviors. Medication use-related unhealthy behaviors are frequently more amenable to change than other categories of unhealthy behaviors. This is due to factors such as the ability to deliver explicit instructions to the patient and the ease of implementing, monitoring and support systems.

    The reduction in dietary-related unhealthy behaviors, while significant and consistent, was less pronounced than the reduction in medication use-related unhealthy behaviors. These results indicate that the integrated care model, while promising, may not be sufficient to ensure consistent adherence to dietary recommendations. The difficulty of implementing dietary interventions in CKD populations is widely acknowledged.28 The formulation of effective strategies to enhance dietary counseling is a complex endeavor, influenced by numerous variables.29 While the integrated care model addresses key factors like group education, live demonstrations, and regular monitoring, incorporating supplementary techniques such as personalized educational sessions, motivational interviewing, and access to affordable healthy food options could significantly enhance the effectiveness of dietary counseling.29

    Yet, there was no significant improvement in lifestyle-related behaviors, specifically exercise and weight control. Regular exercise levels improved initially, but a notable decline occurred in the last year of follow-up. This pattern aligns with the expected response to lifestyle modification programs, characterized by an initial period of improvement, followed by a plateau and a subsequent decline. Weight control is a complex process influenced by numerous factors, including dietary intake, physical activity, sleep patterns, stress management, and smoking cessation. Consequently, weight control is often the most challenging lifestyle modification for CKD patients, which is consistent with our findings.

    Over a 36-month observation period, we aimed to determine if improvements in unhealthy behaviors were associated with a reduced rate of eGFR decline. Unfortunately, we found that individual improvements in specific unhealthy behaviors did not significantly affect the rate of eGFR decline. This lack of impact may be due to the complex and multifaceted mechanisms that contribute to GFR decline in kidney disease. However, we did observe that individuals with a baseline cumulative score of 3 or more unhealthy behaviors experienced a faster rate of eGFR decline compared to those with a score below 3.

    To our knowledge, this is the first longitudinal, prospective observational cohort study of patients with CKD in a primary healthcare setting. This article demonstrates that a structured, integrated care program effectively reduces unhealthy behaviors. The program’s success in slowing the progression of CKD is attributed to a combination of lifestyle modifications and the close control of key clinical and biochemical parameters, as previously shown in our original ESCOR2 study.22 The model is likely to be implemented at a nationwide level. Furthermore, since such program utilized in this study is not a costly or technically advanced intervention, it could be generalized to the other rural communities as well.

    The findings of this study must be interpreted with certain limitations. Firstly, the majority of unhealthy behaviors examined in this study were obtained via self-report, a methodology recognized for its potential limitations in terms of accuracy and reliability. Additionally, most of the enrolled patients had only a primary education level, which could introduce qualitative error, especially in their ability to accurately recall information.

    Secondly, the questionnaires employed for assessment of dietary intake behavior were designed to be both user-friendly for primary health care personnel and suitable for integration into routine clinical practice. Therefore, the list may not be complete. Several food items were omitted from the questionnaire list. Furthermore, some unhealthy behaviors, such as alcohol consumption and illicit drug use, were not included in our study. Accurately measuring these behaviors in Thailand presents significant challenges, and our intervention was not designed to effectively address them.

    Thirdly, information collected by healthcare providers may be biased due to the Hawthorne effect. This occurs when participants who are aware of being observed alter their behavior, often by providing overly positive responses. Finally, it is important to note that we did not collect data on direct outcomes associated with each unhealthy behavior. For example, we did not assess the prevalence of acute kidney injury (AKI) in patients with a history of NSAID use or the correlation between muscle mass and regular exercise.

    While this study provides valuable insights, further research is needed to explore the optimal strategies for promoting sustained behavioral change and to elucidate the precise mechanisms by which these changes impact CKD progression. Future studies should consider incorporating more rigorous assessment methods, such as objective measures of dietary intake and physical activity, to enhance the accuracy of data collection. Additionally, exploring the impact of targeted interventions for specific unhealthy behaviors, such as personalized dietary counseling and tailored exercise programs, may yield more significant results.

    Conclusion

    This study demonstrates the feasibility and effectiveness of an integrated care model in addressing multiple unhealthy behaviors among CKD patients in a primary care setting. The intervention led to significant reductions in medication-related and dietary-related unhealthy behaviors, particularly in the early stages of the study. However, maintaining long-term adherence to lifestyle modifications, especially weight control and physical activity, remains a challenge.

    Data Sharing Statement

    The data supporting the findings of this study are available from the corresponding author (Teerawat Thanachayanont, [email protected]) upon reasonable request.

    Acknowledgments

    Preliminary data analysis from this study was presented as a poster at the 25th World Congress of Nephrology in 2019. https://www.kireports.org/article/S2468-0249(19)30449-8/fulltext.

    Funding

    This study received funding from Bhumirajanagarindra Kidney Institute Hospital, which was not involved in the study’s design, data analysis, or reporting.

    Disclosure

    The authors declare no conflicts of interest in this work.

    References

    1. Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Nephrol Dial Transplant. 2019;34:1803–1805. doi:10.1093/ndt/gfz174

    2. Kovesdy C. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11. doi:10.1016/j.kisu.2021.11.003

    3. Ismail H, Abdul Manaf MR, Abdul Gafor AH, Mohamad Zaher ZM, Nur Ibrahim AI. International comparisons of economic burden of end-stage renal disease to the national healthcare systems. IIUM Med J Malays. 2019;18(3):188–196.

    4. Yeung E, Bello AK, Levin A, et al. Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey. BMJ open. 2021;11(7):1–10. doi:10.1136/bmjopen-2020-047245

    5. Nagassawa H, Sugita I, Tachi T, et al. The relationship between dialysis patients’ quality of life and caregivers’ quality of life. Front Pharmacol. 2018;9:1–10. doi:10.3389/fphar.2018.00770

    6. Kidney Disease Improving Global Outcomes. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117–S314. doi:10.1016/j.kint.2023.10.018

    7. Kittiskulman P, Sripaiboonkij T, Katavetin P, et al. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: a nationwide study. PLoS One. 2018;13(5):1–14.

    8. Ricardo AC, Anderson CA, Yang W, et al. Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Disease. 2015;65:412–424. doi:10.1053/j.ajkd.2014.09.016

    9. Osman NA, Hassanein SM, Leil MM, NasrAllah MM. Complementary and Alternative medicine use among patients with chronic kidney disease and kidney transplant recipients. J Ren Nutr. 2015;25(6):466–471. doi:10.1053/j.jrn.2015.04.009

    10. Tsai MY, Huang YC, Cheng BC, Chin CY, Hsu YT, Lee WC. Prevalence and Varieties of complementary and alternative medicine usage among individuals with pre-dialysis chronic kidney disease in Taiwan: an investigative cross-sectional analysis. BMC Complentary Med Ther. 2024;24:1–11.

    11. Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Prevalence of herbal and dietary supplement usage in Thai outpatients with chronic kidney disease: a cross-sectional survey. BMC Complementary Alternative Med. 2013;13:1–9. doi:10.1186/1472-6882-13-153

    12. Mohammadi S, Asghari G, Emami-Naini A, Mansourian M, Badri S. Herbal supplement use and herb–drug interactions among patients with kidney disease. J Res Pharm Pract. 2020;9(2):61–67. doi:10.4103/jrpp.JRPP_20_30

    13. Ingsathit A, Thakkinstian A, Chaiprasert A. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010;25:1567–1575. doi:10.1093/ndt/gfp669

    14. Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. BMC Complementary Alternative Med. 2014;14:473. doi:10.1186/1472-6882-14-473

    15. Yang B, Xie Y, Guo M, Rosner MH, Yang H, Ronco C. Nephrotoxicity and Chinese herbal medicine. Clin J Am Soc Nephrol. 2018;12:1605–1611. doi:10.2215/CJN.11571017

    16. Kilis-Pstrusinska K, Wiela-Hojenska A. Nephrotoxicity of herbal products in Europe-a review of an underestimated problem. Int J Mol Sci. 2021;22:4132. doi:10.3390/ijms22084132

    17. Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract. 2013;30(3):247–255. doi:10.1093/fampra/cms086

    18. Armstrong MJ, Zhang K, Ye F, Klarenbach SW, Pannu NI. Population-based analysis of nonsteroidal anti-inflammatory drug prescription in subjects with chronic kidney disease. Can J Kidney Health Dis. 2023;10:1–10. doi:10.1177/20543581221149621

    19. Cha’on U, Tippayawat P, Sae-ung N, et al. High prevalence of chronic kidney disease and its related risk factors in rural areas of Northeast Thailand. Sci Rep. 2022;12:1–11.

    20. Jiamjariyapon T, Ingsathit A, Pongpirul K, et al. Effectiveness of integrated care on delaying progression of stage 3–4 chronic kidney disease in rural communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol. 2017;18:83. doi:10.1186/s12882-016-0414-4

    21. Thanachayanont T, Chanpitakkul M, Hengtrakulvenit J, et al. Effectiveness of integrated care on delaying chronic kidney disease progression in rural communities of Thailand (ESCORT-2) trials. Nephrology. 2021;26:333–340. doi:10.1111/nep.13849

    22. Sunpuwan M, Punpuing S, Jaruruengpaisan W, Kinsman J, Wertheim H. What is in the drug packet?: access and use of non-prescribed poly-pharmaceutical packs (Yaa Chud) in the community in Thailand. BMC Public Health. 2019;19(1):971. doi:10.1186/s12889-019-7300-5

    23. Thanachayanont T, Chanpitakkul M, Saetie A, Lekagul S, Tungsanga K. Correlation of the dietary protein intake between those estimated from a short protein food-recall questionnaire and from 24-hour urinary urea-nitrogen excretion in stages 3–4 chronic kidney disease patients. Intl J Nephrol. 2023;2023:1–8. doi:10.1155/2023/9713045

    24. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. doi:10.1016/S0140-6736(03)15268-3

    25. Schrauben SJ, Apple BJ, Chang AR. Modifiable lifestyle behaviors and CKD progression: a narrative review. Kidney 360. 2022;3:752–778. doi:10.34067/KID.0003122021

    26. Evangelidis N, Craig J, Bauman A, Manera K, Saglimbened V, Tong A. Lifestyle behaviour change for preventing the progression of chronic kidney disease: a systematic review. BMJ Open. 2019;9:1–15. doi:10.1136/bmjopen-2019-031625

    27. Phueanpinit P, Pongwecharak J, Krsk J, Jarernsiripornkul N. Evaluation of community pharmacists’ roles in screening and communication of risks about non-steroidal anti-inflammatory drugs in Thailand. Prim Health Care Rev Dev. 2018;19:598–604. doi:10.1017/S1463423618000142

    28. Lambert K, Mansfield K, Mullan J. How do patients and carers make sense of renal dietary advice. A qualitative exploration. J Ren Care. 2018;44:238–250. doi:10.1111/jorc.12260

    29. Pereira RA, Alvarenga MS, Avesani CM, Cuppari L. Strategies designed to increase the motivation for and adherence to dietary recommendations in patients with chronic kidney disease. Nephrol Dial Transplant. 2021;36:2173–2181. doi:10.1093/ndt/gfaa177

    Continue Reading

  • 6 soldiers martyred, 5 terrorists killed as attack thwarted on Federal Constabulary HQ in KP’s Bannu: ISPR – Pakistan

    6 soldiers martyred, 5 terrorists killed as attack thwarted on Federal Constabulary HQ in KP’s Bannu: ISPR – Pakistan

    Six soldiers were martyred and five terrorists were killed as security forces thwarted an attack on the Federal Constabulary (FC) Headquarters in Khyber Pakhtunkhwa’s Bannu district on Tuesday, according to the military’s media wing.

    A statement from the Inter-Services Public Relations (ISPR) issued tonight said: “During early hours of September 2, 2025, in a cowardly terrorist attack, khwarij belonging to Indian proxy Fitna-al-Khwarij targeted FC Headquarters in Bannu district.

    “The Indian sponsored kharjis attempted to breach the perimeter security, however, their nefarious designs were swiftly foiled by the vigilant and resolute response by own troops. In their desperation, the kharjis rammed an explosive-laden vehicle into the perimeter wall. The suicide blast resulted in the partial collapse of the perimeter wall and damage to adjacent civilian infrastructure, inflicting injuries to three innocent civilians.”

    Fitna-al-Khawarij is a term the state uses for terrorists belonging to the banned Tehreek-i-Taliban Pakistan (TTP).

    The ISPR added that in a display of “unwavering courage and professional excellence”, troops engaged the terrorists with precision and eliminated all five of them. The ISPR said six soldiers belonging to the FC and Pakistan Army were martyred in the intense exchange of fire after “putting up a heroic fight”.

    The ISPR said the clearance operation in the area would continue and the perpetrators of the “heinous and cowardly act” would be brought to justice.

    “The security forces of Pakistan in step with nation remain steadfast in their resolve to eradicate Indian sponsored terrorism from the country and such sacrifices of our brave soldiers and innocent civilians further strengthen our unwavering commitment of safeguarding our nation at all costs,” it concluded.

    Over the past few months, multiple areas of KP — including Bannu, Peshawar, Karak, Lakki Marwat and Bajaur — have seen a series of attacks, particularly targeting police personnel in Bannu.

    Bannu Regional Police Officer Sajjad Khan earlier told Dawn.com that five policemen were injured during the operation that was led by Bannu District Police Officer Saleem Abbas inside the FC lines.

    Inspector General of Police (IG) Zulfiqar Hameed said during a media briefing that police, army and FC personnel swiftly responded to the attack and killed four within an hour of the attack and later the fifth was also eliminated.

    The IG said a clearance and search operation was carried out at the site. The operation’s conclusion was later confirmed by RPO Khan.

    Pakistan has seen a surge in terrorism since the TTP ended its ceasefire deal with the government in November 2022, vowing to increase attacks.

    Last month, police, alongside security forces in Hoveed and Wazirabad areas of Bannu, arrested “14 terrorist facilitators“ and destroyed their hideouts.

    On August 3, a police constable was martyred in a terrorist attack on a checkpoint in Bannu, where an exchange of fire also left three terrorists dead and three policemen injured.

    In July, ter­rorists used a quadcopter to attack a police station in Miryan, Bannu, making it the fifth such attack at the installation in a month.

    According to data released by the Islamabad-based think tank Pakistan Institute for Conflict and Security Studies (PICSS), the country witnessed an alarming spike in militant violence in August this year, registering a 74 per cent increase in militant attacks compared to July, becoming the “deadliest month in over a decade“.

    Continue Reading

  • PlayStation announces State of Play focused on 007: First Light for September 3 | News-in-brief – GamesIndustry.biz

    PlayStation announces State of Play focused on 007: First Light for September 3 | News-in-brief – GamesIndustry.biz

    1. PlayStation announces State of Play focused on 007: First Light for September 3 | News-in-brief  GamesIndustry.biz
    2. Gears of War: Reloaded PC Performance Analysis  DSOGaming
    3. PlayStation Just Got One Of The Most Influential Shooters Of All Time  Inverse
    4. Gears of War: Reloaded Platinum Trophy Hints at More PS5 Gears Games  Insider Gaming
    5. Gears of War: Reloaded Players Divided Over Change to the Original Game  ComicBook.com

    Continue Reading

  • Investigation into the Therapeutic Efficacy and Inflammatory Modulator

    Investigation into the Therapeutic Efficacy and Inflammatory Modulator

    Introduction

    Myopia is the most common refractive error among adolescents. With changing modern lifestyles and increased academic burdens, the incidence of myopia has risen dramatically, reaching epidemic proportions globally. The World Health Organization (WHO) estimates that half the world’s population may be myopic by 2050, with high myopia affecting nearly 10%, highlighting a significant public health burden.1,2 According to relevant epidemiological data, the prevalence of myopia in adolescents has reached over 70% in many regions, making it a major global public health challenge.2,3 The rapid progression of myopia not only affects visual quality but may also lead to severe ocular complications, such as retinal detachment, cataracts, glaucoma, and even blindness.3,4 Emerging evidence suggests that inflammatory pathways may play a role in scleral remodeling and axial elongation, a key pathological feature of myopia progression.5 Therefore, controlling myopia progression in adolescents, particularly preventing axial length elongation, remains a critical focus in refractive correction research.

    Orthokeratology (Ortho-K) lenses represent a non-surgical refractive correction method. They utilize customized rigid gas-permeable contact lenses worn overnight to temporarily reshape the cornea, enabling clear daytime vision without glasses or contact lenses.4,6 Ortho-K lenses are effective in slowing adolescent myopia progression, particularly by controlling axial length growth, and offer higher compliance and safety compared to traditional spectacles and soft contact lenses.5,7,8 Consequently, they have become a mainstay treatment option. However, long-term Ortho-K lens wear can be associated with side effects such as discomfort, dry eye symptoms, and corneal staining in some patients.7,9 The integrity and stability of the tear film and ocular surface are crucial factors influencing the safety, comfort, and efficacy of Ortho-K lens wear; disruptions can contribute to inflammation, discomfort, and potential complications.10,11 To optimize treatment outcomes and mitigate adverse effects, researchers have explored combining Ortho-K with pharmacological agents.

    Atropine, a non-selective muscarinic antagonist widely used in ophthalmology, inhibits ciliary muscle contraction and modulates intraocular pressure.8,12 Low-concentration atropine eye drops (0.01%) are recognized as an effective and safe treatment for controlling myopia progression. Previous studies9,13,14 have demonstrated that 0.01% atropine effectively slows axial length elongation and refractive error worsening. Beyond its antimuscarinic effects, atropine exhibits anti-inflammatory properties. It is known to suppress the release of inflammatory cytokines (eg, IL-6, TNF-α) and matrix metalloproteinases (MMPs) in ocular tissues, potentially mitigating inflammation associated with contact lens wear and myopia progression itself.15,16 Therefore, investigating the combined application of Ortho-K lenses and 0.01% atropine presents a promising strategy. However, there is a paucity of clinical trials specifically evaluating the combined effect of these two modalities on ocular inflammatory markers and tear film stability in adolescents.17 This study retrospectively analyzed the clinical data of 90 adolescent myopia patients to explore the therapeutic efficacy and inflammatory modulatory effects, particularly its impact on tear film and ocular surface factors, of combining 0.01% atropine eye drops with Ortho-K lenses, aiming to provide more optimized and comprehensive strategies for clinical myopia control.

    Subjects and Methods

    Study Subjects

    A retrospective analysis was conducted on the clinical data of 90 adolescent myopic patients (90 eyes, all using left eye data) who were treated at our hospital from April 2021 to June 2023. Inclusion criteria: Age 8–18 years, no gender restriction, initial treatment; diagnosed according to clinical standards for adolescent myopia;11 spherical refractive error between −1.0 and −6.0 D, with regular astigmatism < −1.50 D; best corrected visual acuity >1.0; normal fundus and anterior segment, intraocular pressure between 10–21 mmHg; central corneal thickness >0.45 mm, corneal curvature between 39.00–46.00 D; patients and their families provided informed consent and signed the relevant informed consent forms. Exclusion criteria: Patients not meeting the age requirement; patients with strabismus, amblyopia, keratitis, dry eye disease (defined as OSDI score >12, TBUT < 5 seconds, or Schirmer I test <5 mm/5 min), or other significant eye diseases; patients with allergic reactions or contraindications to the operations or medications used in this study; patients with a history of eye surgery; patients with psychiatric disorders and/or autoimmune diseases. Based on the treatment method, patients were divided into a control group (n=45, wearing corneal reshaping lenses) and an observation group (n=45, wearing corneal reshaping lenses combined with 0.01% atropine eye drops). As this was a retrospective study, randomization was not performed; group allocation was determined solely by the treatment regimen chosen and adhered to by the patient and their guardian after detailed counseling by the attending ophthalmologist. Consequently, masking (blinding) of participants and clinicians to the treatment group was not feasible. To account for potential confounding factors known to influence myopia progression,14 available clinical records were reviewed for documentation of parental myopia history and average daily near work/screen time (>4 hours per day vs ≤4 hours).15,16 Data on daily outdoor time, however, were inconsistently recorded in the clinical notes and thus not included in the analysis. The use of data from only the left eye per patient was implemented to ensure statistical independence of observations and avoid the correlation inherent in bilateral data from the same individual, a common methodological approach in ophthalmic studies.17,18 This study was approved by the Changzhi People’s Hospital Medical Ethics Committee (JSJZ24017), and the study strictly adhered to the ethical guidelines of the Declaration of Helsinki. Written informed consent was obtained from the legal guardians of all underage participants, authorizing their participation and the use of their clinical data for research purposes.

    Methods

    All patients underwent routine ophthalmic examinations and cycloplegic refraction. Based on these evaluations, the control group was treated with corneal reshaping lenses. The lenses used were Japanese Alpha corneal reshaping lenses (registration number: Guo Zhu Jin 20163221583). Trial lenses were selected according to the corneal topography’s flat K-value and E-value. After tear stabilization, dynamic and static judgments were made under a slit lamp, adjusting the trial lenses based on lens position, fluorescein staining, and mobility, until the patient was satisfied and comfortable The prescription was collected from the trial lenses, and patients were instructed to wear the lenses for 8 hours at night, removing them in the morning, and to continue wearing them for 1 year, with monthly follow-up visits. In the observation group, 0.01% atropine eye drops were applied in combination with corneal reshaping lenses. The corneal reshaping lens usage followed the same protocol as the control group. Patients were instructed to use 0.01% low-concentration atropine eye drops 30 minutes before wearing the lenses each night. The eye drops were prepared by the hospital pharmacy department by mixing atropine sulfate injection (Tianjin Jinyao Pharmaceutical Co., Ltd., National Drug Approval No. H12020383) and sodium hyaluronate eye drops (Zhuhai Yisheng Biopharmaceutical Co., Ltd., National Drug Approval No. H20183333) in a specified ratio (1:100 dilution to achieve 0.01% atropine concentration). The compounded formulation was prepared under aseptic conditions in batches sufficient for 1 month per patient, stored at 4°C in opaque bottles, and dispensed with clear instructions to patients regarding cold storage and a 28-day discard policy after opening, in accordance with standards for extemporaneous ophthalmic preparations.19 One drop was applied each time, with a frequency of once daily. After instillation, the lacrimal sac was gently pressed for 10 minutes to facilitate drug absorption and reduce systemic side effects. Follow-up in the observation group was consistent with the control group.

    Observation Indicators

    Refractive Effect Indicators

    Refraction, corneal curvature, axial length (AL), central corneal thickness (CCT), and pupil diameter (PD) were measured before treatment and after 1 year of treatment. Refractive error: Measured using a retinoscope after cycloplegia, with results expressed as equivalent spherical power. Corneal curvature: Measured using a CSO corneal topography device. AL: Measured with an anterior segment optical biometer. CCT: Measured with an anterior segment optical biometer. PD: Measured using a CSO corneal topography device.

    Ocular Surface Indicators

    The ocular surface disease index (OSDI)12 was used to evaluate the severity of ocular surface disease before treatment and after 1 year. The scale includes three dimensions: “ocular symptoms”, “visual function”, and “environmental triggers”, with 12 items in total. Each item is scored from 0 to 4, with a total score range of 0–48. Higher scores correlate with greater severity of ocular surface disease. After 1 year, the ocular surface staining score13 was also assessed, with grading based on the severity of conjunctival (using the Oxford Scheme) and corneal (using the NEI/Industry Workshop scale) staining, ranging from 0 to 5 points per region, with higher scores indicating more severe staining.

    Tear Film Indicators

    Non-invasive tear film breakup time (NIBUT) and tear breakup time (TBUT) were measured before treatment and after 1 year. NIBUT: Measured with a comprehensive ocular surface analyzer. TBUT: Measured by fluorescein staining paper. The patient was instructed to blink three times and then gaze straight ahead, after which slit-lamp cobalt blue light was used to observe the tear film and record the first tear film breakup time. The test was repeated three times, and the average value was taken.

    Corneal Endothelial Cell Indicators

    Corneal endothelial cell density (CD) and hexagonal cell percentage (HEX) were measured before treatment and after 1 year using a specular microscope (Konan Noncon ROBO, Japan), with the values measured three times and averaged.

    Inflammatory Factor Indicators

    Tear samples (20 μL) were collected before treatment and after 1 year from the lateral canthus using calibrated glass microcapillary tubes without topical anesthesia, avoiding reflex tearing. Samples were immediately frozen at −80°C. Enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA) were used according to the manufacturer’s instructions to detect interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) levels. All samples were analyzed in duplicate, and the mean value was used.

    Adverse Reaction Incidence

    Adverse reactions, including allergic reactions (eg, conjunctival hyperemia, itching, eyelid swelling), photophobia, diagnosed conjunctivitis or keratitis (by slit-lamp examination), persistent foreign body sensation (>1 week), and significant pupil dilation (>6mm in photopic conditions), were recorded prospectively by the medical staff at our hospital during each monthly follow-up visit and documented in the patient record. The severity of adverse events was graded as mild (transient, no intervention), moderate (required intervention or temporary discontinuation), or severe (discontinued treatment, required medical therapy).20

    Statistical Analysis

    GraphPad Prism 8 software was used for charting; SPSS 23.0 software was used for data processing. For count data, the results are expressed as percentages (%) and analyzed using the chi-square test or Fisher’s exact test, as appropriate. For measurement data, results are expressed as mean ± standard deviation (mean ± SD). Normality of data distribution was assessed using the Shapiro–Wilk test. Homogeneity of variance was assessed using Levene’s test. Independent sample t-tests were used for normally distributed comparisons between two groups, and the Mann–Whitney U-test was used for non-normally distributed data. Paired t-tests or Wilcoxon signed-rank tests were used for comparisons within the same group before and after treatment, depending on data distribution. A formal power calculation was not performed a priori for this retrospective study. However, the sample size (n=45 per group) is comparable to or larger than those used in similar published studies investigating combination myopia control therapies.21,22 A P value <0.05 was considered statistically significant.

    Results

    Comparison of Clinical Data

    There were no significant differences between the control group and the observation group in terms of gender, age, equivalent spherical degree, intraocular pressure, parental myopia history, or high near work/screen time (P > 0.05), indicating comparability. See Table 1.

    Table 1 Comparison of Clinical Data (, n[%])

    Comparison of Correction Effect Indicators

    After one year of treatment, the refractive degree, AL, and PD of both groups increased compared to before treatment, while corneal curvature and CCT decreased. The refractive degree, corneal curvature, AL, and CCT of the observation group were significantly lower than those of the control group after one year of treatment, and the PD of the observation group was higher (P < 0.05). The mean axial length (AL) increase in the observation group (0.12 ± 0.08 mm) was 42.9% lower than in the control group (0.21 ± 0.09 mm) (P<0.001), a difference considered clinically significant for myopia control based on established thresholds.23 The observed pupil dilation (PD) in the observation group (+0.55 ± 0.23 mm) aligns with known antimuscarinic effects of atropine,24 though remained within physiological ranges. See Table 2.

    Table 2 Comparison of Correction Effect Indicators ()

    Comparison of Ocular Surface Indicators

    After one year of treatment, both groups exhibited increased Ocular Surface Disease Index (OSDI) scores compared to baseline. However, the observation group showed significantly lower post-treatment scores than the control group (Control: 18.2 ± 4.3 vs Observation: 15.6 ± 3.8; P = 0.002), with a mean difference of 2.6 points (95% CI: 1.1–4.1). Additionally, corneal staining scores were significantly lower in the observation group (1.8 ± 0.7) compared to the control group (2.6 ± 0.9; P < 0.001), indicating improved ocular surface integrity in patients receiving combination therapy. See Figure 1A and B.

    Figure 1 Comparison of Ocular Surface Indicators (, Score).

    Notes: (A) OSDI Score; (B) Ocular Surface Staining Score. a indicates P < 0.05 compared to pre-treatment within the same group; b indicates P < 0.05 compared to the control group at the same time point.

    Comparison of Tear Film Indicators

    Following treatment, both Non-Invasive Break-Up Time (NIBUT) and traditional Tear Break-Up Time (TBUT) decreased in the two groups. However, the decline was significantly less in the observation group, indicating better tear film stability. The observation group demonstrated longer NIBUT values (10.6 s; 95% CI: 9.7–11.5) compared to the control group (9.7 s; 95% CI: 8.9–10.5; P = 0.016). Similarly, TBUT was higher in the observation group (10.0 s; 95% CI: 9.2–10.8) than in the control group (9.3 s; 95% CI: 8.6–10.0; P = 0.038). The between-group differences (approximately 0.9–1.3 seconds) suggest clinically meaningful preservation of tear film function. See Figure 2A and B.

    Figure 2 Comparison of Tear Film Indicators (, s).

    Notes: (A) NIBUT; (B) TBUT. a indicates P < 0.05 compared to pre-treatment within the same group; b indicates P < 0.05 compared to the control group at the same time point.

    Comparison of Corneal Endothelial Cell Indicators

    There were no statistically significant differences between groups in changes to corneal endothelial cell density (CD) or hexagonality percentage (HEX) after treatment. CD decreased slightly in both groups (Control: −10.7 cells/mm²; 95% CI: −45.2 to 23.8 vs Observation: −11.0 cells/mm²; 95% CI: −49.1 to 27.1; P = 0.982). Similarly, HEX showed minor reductions (Control: −0.58%; 95% CI: −2.1 to 0.9 vs Observation: −0.93%; 95% CI: −2.4 to 0.5; P = 0.674). These changes were minimal and fell within the range of normal physiological variation, indicating no clinically significant endothelial cell loss. See Figure 3.

    Figure 3 Comparison of Corneal Endothelial Cell Indicators ().

    Notes: (A) CD; (B) HEX.

    Comparison of Inflammatory Factor Indicators

    Analysis of tear fluid inflammatory markers revealed that although both groups showed post-treatment increases in pro-inflammatory cytokines, the observation group exhibited significantly smaller elevations. The mean increases in IL-1β, IL-6, and TNF-α were lower in the observation group compared to the control group (IL-1β: +1.79 pg/mL vs +3.05 pg/mL, P < 0.001; IL-6: +0.65 pg/mL vs +1.63 pg/mL, P = 0.003; TNF-α: +7.16 pg/mL vs +11.58 pg/mL, P < 0.001). These findings suggest that the combination therapy may provide better control of subclinical ocular surface inflammation. See Figure 4.

    Figure 4 Comparison of Inflammatory Factor Indicators ().

    Notes: (A) IL-1β; (B) IL-6; (C) TNF-α. a indicates P < 0.05 compared to pre-treatment within the same group; b indicates P < 0.05 compared to the control group at the same time point.

    Comparison of Adverse Reaction Incidence

    The overall incidence of adverse reactions did not differ significantly between groups (P=0.235). Most events were mild (80.0% control, 85.7% observation). One case of moderate keratitis in the observation group resolved with temporary discontinuation. Severe adverse reactions requiring treatment discontinuation did not occur. See Table 3.

    Table 3 Comparison of Adverse Reactions (n[%])

    Discussion

    Orthokeratology lenses are rigid contact lenses specifically designed for myopic patients. Their unique nighttime wear method temporarily alters the shape of the cornea by flattening its curvature, which helps to reduce myopia.24 This process not only effectively slows down the axial length growth but also improves vision, allowing patients to go without glasses or contact lenses during the day.25 Clinical studies26 have shown that for juvenile myopic patients with refractive errors between −1.00 and −6.00 D, orthokeratology lenses can significantly reduce the rate of axial length growth and have a stabilizing effect on peripheral refractive shift, which helps prevent further myopic progression. On the other hand, atropine eye drops help slow myopia progression by affecting the retina and scleral axial elongation. The mechanism of action involves the blockade of muscarinic receptors and stimulation of α2-adrenergic receptors, intervening in the process of axial elongation.27 Previous clinical studies28,29 have shown that 0.01% atropine is an effective myopia control drug with almost no side effects, and it can reduce approximately 70% of myopia progression. However, despite the effectiveness of 0.01% atropine eye drops in controlling myopia progression, using this medication alone cannot fully prevent the onset of myopia and needs to be combined with other vision correction methods. Recent studies30,31 suggest that the combined use of low-concentration atropine with orthokeratology lenses provides better myopia control than either treatment alone. The results of this study are consistent with previous findings, further confirming that this combination therapy achieves more positive clinical effects in several aspects when compared to monotherapy.

    The progression of myopia is often accompanied by an increase in AL, and an increase in PD is believed to slow down AL growth.32 Studies33 have shown that orthokeratology lenses are significantly more effective than traditional single-vision lenses in controlling AL growth. In this study, after one year of treatment, the increase in axial length in the observation group was significantly lower than that in the control group, while the increase in PD was significantly higher than that in the control group (P<0.05). This phenomenon can be explained by the mechanism of action of orthokeratology lenses. Orthokeratology lenses apply continuous mechanical pressure on the cornea, flattening its central curvature, which reduces myopia and delays axial elongation. The change in peripheral refractive power, especially the increase in PD, may be related to the structural adjustments in the cornea and the peripheral refractive changes caused by the orthokeratology lenses, which help slow further axial elongation. Additionally, the combined use of low-concentration 0.01% atropine eye drops may also play an important role in controlling axial elongation. Although the mechanism of 0.01% atropine is not yet fully understood, studies34 suggest that it may help slow axial growth by improving the morphology of the sclera, promoting increased scleral thickness, and enhancing the thickness of the nerve fiber layer.

    The treatment effectiveness of myopia in adolescents largely depends on patient compliance, which is closely related to ocular comfort. In this study, the OSDI score after one year of treatment was higher than before treatment in both groups, indicating that wearing orthokeratology lenses increased ocular discomfort. However, the OSDI score of the observation group after treatment was significantly lower than that of the control group, suggesting that the combined treatment of orthokeratology lenses and 0.01% atropine eye drops alleviated ocular discomfort. This improvement may be closely related to the components and mechanism of action of 0.01% atropine eye drops. Not only does 0.01% atropine help control myopia progression, but its formulation also contains polyethylene glycol, which is widely used in ophthalmic medications to relieve burning, stinging, and dryness, thereby increasing comfort for glasses or contact lens wearers.35 Experimental studies confirm that PEG-based lubricants enhance corneal epithelial barrier function by upregulating tight junction proteins (ZO-1, occludin) and reducing desquamation.36 Furthermore, the observation group showed significantly lower ocular surface staining scores compared to the control group, further supporting the advantage of combined therapy in reducing ocular discomfort. Ocular surface staining scores typically reflect the health status of the cornea and conjunctiva, and lower staining scores indicate less ocular surface damage.37 The reduction in ocular surface staining scores in the observation group may be due to the alleviation of mechanical stimulation caused by orthokeratology lenses through 0.01% atropine eye drops.

    Tear film stability is an important factor affecting ocular health, and NIBUT (Non-invasive Breakup Time) and TBUT (Tear Breakup Time) are commonly used indicators for evaluating tear film stability. In this study, both NIBUT and TBUT were significantly lower after treatment in both groups, suggesting that tear film stability had changed during the treatment. Possible reasons for this include: (1) direct contact of orthokeratology lenses with the cornea reduces the oxygen supply to the corneal surface during blinking, which affects the distribution and flow of tear fluid, leading to decreased tear film stability;38 (2) the wearing of orthokeratology lenses may directly impact the tear film structure, especially the thickness of the lipid layer, thereby worsening tear film function; (3) orthokeratology lenses may inhibit corneal sensory nerves, resulting in reduced blink activity, which negatively impacts tear film stability.39 However, the observation group showed significantly longer NIBUT and TBUT than the control group, indicating that the combined treatment had certain advantages in improving tear film stability. This improvement may be due to: (1) 0.01% atropine, through its effect on neurotransmitter release, helping maintain the structural integrity of corneal epithelial cells; (2) 0.01% atropine eye drops also contain polyethylene glycol, which includes hydroxypropyl guar gum. After binding with inorganic salt ions, this forms high molecular weight gel compounds that can create a long-lasting lubricating film on the ocular surface, maintaining ocular moisture; (3) polyethylene glycol eye drops also promote the proliferation of goblet cells on the ocular surface,40 as demonstrated in murine dry eye models where PEG increased MUC5AC expression by 40% compared to controls.41

    The use of orthokeratology lenses, especially during the night, has garnered significant attention due to its impact on the cornea. Since these lenses directly contact the cornea and apply constant mechanical pressure while being worn during sleep, this unique usage pattern could potentially affect the corneal structure and function. Of particular concern is the health and function of the corneal endothelial cells. However, there is no unified conclusion in current research regarding whether orthokeratology lenses have adverse effects on endothelial cells after long-term or short-term use. This study observed that, in patients treated with orthokeratology lenses combined with 0.01% atropine eye drops for one year, both CD and HEX values decreased post-treatment. However, the inter-group comparison before and after treatment showed no significant changes, and no treatment-related abnormalities were observed. These results suggest that wearing orthokeratology lenses in combination with low-concentration atropine eye drops has a negligible impact on corneal endothelial cell function.

    Regarding inflammatory responses, this study found that the levels of inflammatory factors such as IL-1β, IL-6, and TNF-α were significantly higher in both groups after one year of treatment compared to pre-treatment levels. This phenomenon may be related to the mechanical pressure effect caused by wearing orthokeratology lenses. The lens’s compression might increase the osmotic pressure of the tear fluid, thus activating ocular immune responses and triggering a series of inflammatory reactions.42 Clinically, this mild elevation in inflammatory markers—though statistically significant—remains within subclinical ranges and has not been associated with symptomatic ocular surface disease in our cohort. Similar transient cytokine increases have been reported in OK lens wearers without clinical sequelae, suggesting an adaptive response rather than pathological inflammation.43 Importantly, no patients developed sight-threatening complications (eg, microbial keratitis) during the study period, supporting the safety profile of combined therapy despite biomarker fluctuations. Additionally, long-term use of orthokeratology lenses may lead to structural changes in the cornea, further affecting the stability of the ocular surface and promoting an increase in inflammatory factor levels. However, the observation group had significantly lower IL-1β, IL-6, and TNF-α levels after one year of treatment compared to the control group. This difference may be attributed to the effect of low-concentration atropine eye drops. The 0.01% atropine eye drops contain polyethylene glycol, which can effectively repair cell membranes and help restore the normal physiological functions of damaged cells. Polyethylene glycol also has certain antioxidant properties, which can alleviate oxidative stress in the eye and inhibit inflammation caused by orthokeratology lenses. Furthermore, 0.01% atropine eye drops may reduce the release of local inflammatory factors by inhibiting the activation of phagocytic cells. Therefore, the combined use of 0.01% atropine eye drops may mitigate the inflammatory response caused by wearing orthokeratology lenses. In terms of safety, there were no statistically significant differences in the adverse reaction rates between the two groups during treatment (P > 0.05), suggesting that the combination of orthokeratology lenses and 0.01% atropine eye drops is safe. This result aligns with previous related studies and provides strong support for the clinical application of this combined treatment method in adolescent myopia control.

    Limitations

    Despite offering valuable clinical data, this study has several limitations. First, it is a retrospective analysis without a randomized controlled trial (RCT) design, which introduces the possibility of selection bias and confounding factors. Although strict inclusion criteria were applied to reduce interference, future studies should validate the effectiveness and safety of combination therapy through prospective, randomized trials. Second, the sample size was relatively small, involving only 90 adolescent patients from a narrow age range, which may limit the generalizability of the findings. Expanding the study population to include different age groups and degrees of myopia would enhance the external validity. Third, the measurement of inflammatory biomarkers was limited by tear sample volume constraints (≤5 μL per collection), which prevented multiplex cytokine profiling and duplicate assays. Additionally, variability in tear collection methods (eg, capillary tubes vs Schirmer strips) and differences in assay sensitivity may influence cytokine quantification. Future studies should adopt standardized sampling protocols and include spike-and-recovery validation to improve data accuracy. Furthermore, this study mainly focused on clinical and biological endpoints such as refractive error, ocular surface changes, and inflammation, without assessing long-term outcomes like treatment adherence, patient-reported symptoms, or quality of life. Including such measures in future research would provide a more comprehensive understanding of treatment impact. Lastly, while low-concentration atropine is generally considered safe, the long-term effects on ocular tissues remain unclear. Future studies should investigate prolonged use, dose-dependence, and potential cumulative toxicity of atropine over extended follow-up periods.

    Conclusion

    The combined treatment of 0.01% atropine eye drops and orthokeratology lenses effectively improves myopia correction outcomes, enhances ocular surface health and tear film stability, and reduces inflammatory responses, without increasing the risk of adverse reactions. This approach offers a safe and efficacious strategy for the comprehensive management of adolescent myopia and holds meaningful clinical application value. Future studies should continue to evaluate its long-term effects through larger, prospective investigations.

    Disclosure

    The authors report no conflicts of interest in this work.

    References

    1. Public Health Ophthalmology Branch of Chinese Preventive Medicine Association. 儿童青少年近视防控公共卫生策略分期专家共识 [Expert consensus on stages of public health strategies for myopia prevention and control in children and adolescents]. Zhonghua Yu Fang Yi Xue Za Zhi. 2023;57(6):806–814. Chinese. doi:10.3760/cma.j.cn112150-20221002-00955

    2. Singh H, Singh H, Latief U, et al. Myopia, its prevalence, current therapeutic strategy and recent developments: a review. Indian J Ophthalmol. 2022;70(8):2788–2799. doi:10.4103/ijo.IJO_2415_21

    3. He XG, Zhang X, Xu X. [Orderly promoting myopia screening, refractive archives establishment, and the closed-loop management of myopia prevention and control for children and adolescents]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(4):551–555. Wolof. doi:10.3760/cma.j.cn112150-20201208-01435

    4. Qian DJ, Wang C, Zhong H, et al. [Epidemiology and the risk factors of myopia among children and youths in Yunnan province]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(4):465–470. Wolof. doi:10.3760/cma.j.cn112150-20200521-00765

    5. Lyu YY, Wu JJ, Guo W, et al. [Clinical observation and analysis on the effect of orthokeratology in myopic anisometropic children]. Zhonghua Yu Fang Yi Xue Za Zhi. 2021;55(4):471–477. Wolof. doi:10.3760/cma.j.cn112150-20210203-00119

    6. Jiang DD, Zhao CP, Ding WZ, et al. [The role of peripheral retinal defocus in myopia progression]. Zhonghua Yan Ke Za Zhi. 2024;60(6):541–546. Hausa. doi:10.3760/cma.j.cn112142-20231024-00173

    7. Xu XL, Lin X, Zhao LH, et al. [Long-term prevention and control effects of orthokeratology lenses designed for small treatment zones on children and adolescents with myopia]. Zhonghua Yan Ke Za Zhi. 2023;59(6):444–451. Hausa. doi:10.3760/cma.j.cn112142-20220929-00476

    8. Sun XX, Zhang Y, Chen YG. [Correlation between the increase in corneal higher-order aberrations and the control of children’s myopic anisometropia after wearing orthokeratology lenses]. Zhonghua Yan Ke Za Zhi. 2022;58(4):250–258. Hausa. doi:10.3760/cma.j.cn112142-20210715-00337

    9. Chen Y, Xiong R, Chen X, et al. Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial. Transl Vis Sci Technol. 2022;11(10):33. doi:10.1167/tvst.11.10.33

    10. Huang Z, Chen X-F, He T, et al. Synergistic effects of defocus-incorporated multiple segments and atropine in slowing the progression of myopia. Sci Rep. 2022;12(1):22311. doi:10.1038/s41598-022-25599-z

    11. Chiang ST, Turnbull PRK, Phillips JR. Additive effect of atropine eye drops and short-term retinal defocus on choroidal thickness in children with myopia. Sci Rep. 2020;10(1):18310. doi:10.1038/s41598-020-75342-9

    12. Public Health Ophthalmology Branch, and Preventive Medicine Association. 中国儿童青少年近视防控公共卫生综合干预行动专家共识 [Chinese expert consensus on comprehensive public health intervention for myopia prevention and control in children and adolescents]. Zhonghua Yi Xue Za Zhi. 2023;103(38):3002–3009. Chinese. doi:10.3760/cma.j.cn112137-20230613-00996

    13. Li J, Ye QQ, Luo XH, et al. [Effect of binocular accommodation and vergence function examinations and interventions on subjective discomfort of dry eye]. Zhonghua Yi Xue Za Zhi. 2021;101(32):2519–2524. Danish. doi:10.3760/cma.j.cn112137-20210331-00788

    14. Liu SW, Zhao YH, Ma J, et al. [Efficacy evaluation of 0.05% cyclosporine A and 0.1% tacrolimus eye drops in the treatment of severe dry eye associated with chronic graft-versus-host disease]. Zhonghua Yan Ke Za Zhi. 2023;59(10):805–813. Hausa. doi:10.3760/cma.j.cn112142-20221112-00585

    15. Zhang XJ, Zaabaar E, French AN, et al. Advances in myopia control strategies for children. Br J Ophthalmol. 2025;109(2):165–176.

    16. Yang Y, Xiao Z, Ouyang J, Guo Y. A novel approach: enhancing adolescent myopia control with orthokeratology and atropine. 2024.

    17. Xiao L, Lv J, Zhu X, et al. Therapeutic effects of orthokeratology lens combined with 0.01% atropine eye drops on juvenile myopia. Arquivos brasileiros de oftalmologia. 2023;87:e2022–0247. doi:10.5935/0004-2749.2022-0247

    18. Wu H, Peng T, Zhou W, et al. Choroidal vasculature act as predictive biomarkers of long-term ocular elongation in myopic children treated with orthokeratology: a prospective cohort study. Eye Vision. 2023;10(1):27. doi:10.1186/s40662-023-00345-2

    19. Tan Q. Combined atropine with orthokeratology in childhood myopia control (AOK)–a randomized controlled trial. 2021.

    20. Ruan Y, Qian L, Chen S. Effect of combined use of orthokeratology and atropine eye drops on correction of myopia in young children, and its influencing factors. Trop J Pharm Res. 2022;21(11):2479–2485.

    21. Pugazhendhi S, Ambati B, Hunter AA. Pathogenesis and prevention of worsening axial elongation in pathological myopia. Clin Ophthalmol. 2020;14:853–873. doi:10.2147/OPTH.S241435

    22. National Academies of Sciences, Engineering, and Medicine. Current and emerging treatment options for myopia. In: Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease. National Academies Press (US); 2024.

    23. Khanal S, Tomiyama ES, Harrington SC, et al. Childhood myopia part II: treatment mechanisms, emerging options, and considerations. Invest Ophthalmol Visual Sci. 2025;66(7):7. doi:10.1167/iovs.66.7.7

    24. Gong G, Zhang BN, Guo T, et al. Efficacy of orthokeratology lens with the modified small treatment zone on myopia progression and visual quality: a randomized clinical trial. Eye Vision. 2024;11(1):35. doi:10.1186/s40662-024-00403-3

    25. Ni NJ, Ma F-Y, Wu X-M, et al. Novel application of multispectral refraction topography in the observation of myopic control effect by orthokeratology lens in adolescents. World J Clin Cases. 2021;9(30):8985–8998. doi:10.12998/wjcc.v9.i30.8985

    26. Ma W, Yang B, Wang X, et al. [Observational comparison of the safety and effectiveness of myopic children wearing defocus incorporated soft contact lenses or orthokeratology lenses]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54(1):181–185. Danish. doi:10.12182/20230160207

    27. Chen XH, Xiong Y, Wang J-L, et al. [Prospective study on corneal safety evaluation of children/adolescents with low and moderate myopia after long-term orthokeratology]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2021;52(6):1006–1010. Danish. doi:10.12182/20211160107

    28. Tsai WS, Wang JH, Chiu CJ. A comparative study of orthokeratology and low-dose atropine for the treatment of anisomyopia in children. Sci Rep. 2020;10(1):14176. doi:10.1038/s41598-020-71142-3

    29. Nucci P, Lembo A, Schiavetti I, et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS One. 2023;18(2):e0281816. doi:10.1371/journal.pone.0281816

    30. Loughman J, Lingham G, Nkansah EK, et al. Efficacy and safety of different atropine regimens for the treatment of myopia in children: three-year results of the MOSAIC randomized clinical trial. JAMA Ophthalmol. 2025;143:134. doi:10.1001/jamaophthalmol.2024.5703

    31. Guo Y, Liu Y, Hu Z, et al. Efficacy and safety of 0.01% atropine combined with orthokeratology lens in delaying juvenile myopia: an observational study. Medicine. 2024;103(24):e38384. doi:10.1097/MD.0000000000038384

    32. Zhao Q, Hao Q. Comparison of the clinical efficacies of 0.01% atropine and orthokeratology in controlling the progression of myopia in children. Ophthalmic Epidemiol. 2021;28(5):376–382. doi:10.1080/09286586.2021.1875010

    33. Zhao Y, Yang B, Li X, et al. [Efficacy of combining highly aspherical lenslets spectacles with 0.01% atropine eye drops in myopia control]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2024;55(5):1280–1287. Danish. doi:10.12182/20240960109

    34. Lin L, Zhang X, Huang C, et al. Evaluation of retinal vascular density and related factors using OCTA in children and adolescents with myopia without maculopathy. J Int Med Res. 2023;51(1):3000605221150136. doi:10.1177/03000605221150136

    35. Xia L, Zhao H, Wang Y. Effect of 0.01% Atropine on diopter and optic axis in adolescents and children with myopia. J Pak Med Assoc. 2023;73(3):656–658. doi:10.47391/JPMA.6241

    36. Sun Y, Sha Y, Yang J, et al. Collagen is crucial target protein for scleral remodeling and biomechanical change in myopia progression and control. Heliyon. 2024;10(15).

    37. Guo L, Fan L, Tao J, et al. Use of topical 0.01% atropine for controlling near work-induced transient myopia: a randomized, double-masked, placebo-controlled study. J Ocul Pharmacol Ther. 2020;36(2):97–101. doi:10.1089/jop.2019.0062

    38. Zheng N, Zhu SQ. Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome. World J Clin Cases. 2023;11(28):6774–6781. doi:10.12998/wjcc.v11.i28.6774

    39. Zhu Q, Zhao Q. Short-term effect of orthokeratology lens wear on choroidal blood flow in children with low and moderate myopia. Sci Rep. 2022;12(1):17653. doi:10.1038/s41598-022-21594-6

    40. Huang Z, Zhao W, Mao Y-Z, et al. Factors influencing axial elongation in myopic children using overnight orthokeratology. Sci Rep. 2023;13(1):7715. doi:10.1038/s41598-023-34580-3

    41. Xun Q, Mei W, Zhang X, et al. Frontiers of myopia research in the 21st century: a bibliometric analysis of the top 100 most influential articles in the field. Medicine. 2024;103(42):e40139. doi:10.1097/MD.0000000000040139

    42. Lee SS, Lingham G, Clark A, et al. Choroidal changes during and after discontinuing long-term 0.01% atropine treatment for myopia control. Invest Ophthalmol Vis Sci. 2024;65(10):21. doi:10.1167/iovs.65.10.21

    43. Lin HJ, Wei -C-C, Chang C-Y, et al. Role of chronic inflammation in myopia progression: clinical evidence and experimental validation. EBioMedicine. 2016;10:269–281. doi:10.1016/j.ebiom.2016.07.021

    Continue Reading

  • Pig Lung Transplant Lasts 9 Days – Medscape

    1. Pig Lung Transplant Lasts 9 Days  Medscape
    2. Gene-edited pig lung transplanted into a brain-dead patient for first time  statnews.com
    3. Pig-to-human lung xenotransplantation into a brain-dead recipient  Nature
    4. Surgeons transplant pig lung into brain dead human recipient for first time  The Guardian
    5. Science news this week: A world first pig-to-human lung transplant, and SpaceX’s Starship nails a test flight  Live Science

    Continue Reading

  • Gastroenterologist lists warning signs of lactose intolerance, shares 4 nutritional alternatives: Protein to vitamin D | Health

    Gastroenterologist lists warning signs of lactose intolerance, shares 4 nutritional alternatives: Protein to vitamin D | Health

    Lactose intolerance is the condition where a person is unable to digest the lactose present in milk and dairy products. In an interview with HT Lifestyle, Dr. Shivani Deswal, senior consultant and clinical lead, paediatric gastroenterologist, Narayana Superspeciality Hospital, Gurgaon expained how lactose intolerance works. Also read | Lactose intolerance: Expert on signs and symptoms to identify it, managing tips

    Lactose intolerance can cause bloating and flatulence.(Freepik)

    He added, “In some people, due to less levels of the lactase enzyme in the small intestine, it becomes difficult for the body to digest the sugar (known as, lactose) present in milk and dairy products, this inability is known as lactose intolerance.”

    Is lactose intolerance similar to milk allergy?

    “Unlike milk allergy (an immune-mediated reaction), lactose intolerance is not life-threatening but can cause significant discomfort and affect dietary quality and variety,” the gastroenterologist explained.

    Lactose intolerance symptoms:

    The doctor noted the symptoms of lactose intolerance that usually start to appear within 30 minutes to 2 hours of consuming lactose. “These may include bloating, abdominal distension, loose stools or diarrhoea, excessive gas, abdominal cramps or pain, and occasionally nausea or vomiting. In children, it can present as recurrent abdominal pain, irritability, or refusal to drink milk.”

    Lactose intolerance is not as same as dairy allergy.(Freepik)
    Lactose intolerance is not as same as dairy allergy.(Freepik)

    Nutritional alternatives to lactose:

    1. Plant-based milks: For anyone avoiding cow’s milk, plant-based options like soy, oat, almond, and pea milk can be excellent choices. The key is to pick versions that are fortified with calcium and vitamin D, since these nutrients are vital for strong bones and healthy growth. Soy and pea milks are the most similar to cow’s milk in terms of nutrition, especially protein, making them good everyday replacements. Almond and oat milks are lighter, but still useful if included alongside other protein-rich foods. Also read | Are you lactose intolerant? Doctor says, it’s different from being allergic to dairy

    2. Calcium sources: Calcium doesn’t have to come only from milk. Foods like tofu, ragi (finger millet), sesame seeds, almonds, and leafy greens all contribute to bone health. For children and adults alike, including these in daily meals helps build a balanced, nourishing diet. Traditional foods such as ragi porridge or millet rotis are naturally rich in calcium, while sesame paste (tahini) or a handful of almonds can make easy, healthy snacks.

    3. Vitamin D: Even with good calcium intake, bones cannot stay strong without enough vitamin D. Sunlight is a natural source, but lifestyle, weather, or skin sensitivity often limit exposure. For this reason, many people, especially children, may need supplements after medical advice. Vitamin D also helps reduce the risk of bone weakness later in life, making it an important part of daily nutrition.

    4. Protein sources: Milk is a natural protein source, but if it’s avoided, it’s important to make up for it with other foods. Soy milk and pea-protein drinks are excellent substitutes, as they provide good quality protein. For those who prefer almond or oat milk, pairing them with foods like pulses, lentils, chickpeas, or tofu ensures the diet remains well-balanced. Also read | Dietician explains if lactose-intolerant people are missing out on calcium; suggests 5 alternatives for dairy-free diet

    Note to readers: This article is for informational purposes only and not a substitute for professional medical advice. Always seek the advice of your doctor with any questions about a medical condition.

    Continue Reading

  • UNIQLO to Substantially Expand the UNIQLO UNIFORM Service for Companies and Organizations – Allowing everyone to feel comfortable while working, learning, and playing

    UNIQLO to Substantially Expand the UNIQLO UNIFORM Service for Companies and Organizations – Allowing everyone to feel comfortable while working, learning, and playing

    Last Updated: 2025.09.02

    UNIQLO to Substantially Expand the UNIQLO UNIFORM Service for Companies and Organizations – Allowing everyone to feel comfortable while working, learning, and playing

    UNIQLO CO., LTD.
    to Japanese page

    Global apparel retailer UNIQLO today announced that it is revamping the structure of the UNIQLO UNIFORM business, significantly expanding its operations in response to growing demand. The number of companies, schools, and sports teams using UNIQLO clothing as work wear and uniforms is projected to exceed 20,000 during the fiscal year ending August 2026.

    With the blurring of work-life boundaries, and greater diversification in attitudes toward work and working styles, many people want to work in ways that allow them to be themselves and feel relaxed and comfortable. These changes are also spreading beyond workplaces to the spaces where people learn, and enjoy sports and community activities.

    Amid these changes, UNIQLO’s approach of making simple, high-quality, everyday clothing with a practical sense of beauty and attention to detail has naturally begun to be accepted for work wear, school uniforms, and sports uniforms. By expanding the UNIQLO UNIFORM business, the LifeWear philosophy of designing clothing to make everyone’s life better extends to even more aspects of daily life.

    In addition to the convenience of being able to choose from standard UNIQLO products, UNIQLO UNIFORM offers a broad lineup that allows organizations to find clothing with the functionality and practicality needed for work, study, or activities, such as being cool or warm, ease of movement, and being easy to clean, all in a variety of colors and patterns to lift the spirit. The large volume of items at affordable prices has attracted support from companies and schools, as well as customers looking for clothing for small groups and organizations.

    In response to feedback and requests from numerous corporations, organizations, and groups, UNIQLO is strengthening its sales, inventory management, and production systems to improve and update clothes, delivering the items customers want in the required quantities, and with short delivery times. UNIQLO is redefining the concept of uniforms for work, school, and sports. With clothing made from the wearer’s point of view and the best service, UNIQLO is changing for the better the places where we work, learn, and participate in sports and community activities.

    UNIQLO UNIFORM Official Online Store

    Visit the official online store (Japanese only: https://www.uniqlo.com/customize/tairyo/ or scan the QR code on the left) to view the product catalog for corporations and organizations. Orders can be delivered in as little as three days from confirmation (if no embroidery or other processing is required).

    UNIQLO UNIFORM Customer Contact

    Frequently Asked Questions (Japanese only): https://www.uniqlo.com/customize/tairyo/#faq
    Enquiries (Japanese only): https://faq.uniqlo.com/contactus/uq_customize_form
    Tel: 0120 697 660 (Toll free in Japan) (Business hours: 9:00-17:00, excluding weekends and public holidays)

     

    Top of page

     

    Continue Reading

  • Jiri Lehecka: Golf, Scottie Scheffler's mentality & facing Carlos Alcaraz – ATP Tour

    1. Jiri Lehecka: Golf, Scottie Scheffler’s mentality & facing Carlos Alcaraz  ATP Tour
    2. Jiri Leheçka vs Carlos Alcaraz Prediction: Arthur Ashe Stadium Set for Seed No.20 Lehečka Against World No.2 Alcaraz  Telecom Asia Sport
    3. Schedule and where to watch Carlos Alcaraz’s quarterfinals at the US Open 2025  Punto de Break
    4. US Open Star Reveals How a Hospital Visit Changed His Life: “It’s the End of the World for Me”  EssentiallySports
    5. Jiri Lehecka Sheds Light on Perspective Change After Meeting Happy Kids in Hospital Ahead of Carlos Alcaraz US Open Clash  Yardbarker

    Continue Reading

  • Parental Perspectives on Childhood Vaccination: Analysing Knowledge an

    Parental Perspectives on Childhood Vaccination: Analysing Knowledge an

    Introduction

    Vaccination is one of the key strategies for preventing pediatric diseases, which has contributed to a 24% global decrease in the death rate for children under five.1 The primary aim of vaccination is to stimulate the immune system’s response against infection and stop the development of serious diseases in childhood by ensuring adequate immunization coverage.2

    The World Health Organization (WHO) has advised against delays or disruptions in immunization services. Despite this recommendation and the efforts of the Ministry of Health to inform the population, it was discovered that 26% of parents in Saudi Arabia did not vaccinate their children on schedule following the national immunization guidelines under normal circumstances.3

    The Saudi national immunization program began in 1979, initially focusing on diphtheria, tetanus, and pertussis (DTP) and later expanding to include other vaccines. Vaccination is mandatory for school entry, contributing to high coverage rates (98% for DTP and MMR in 2019).4 This school requirement can be an effective strategy for ensuring high immunization rates.5

    The primary and most important individuals who make decisions about children’s health are their parents. They are the only ones who can drive and significantly promote the implementation of full immunization programs and higher compliance rates. They can experience “vaccine hesitancy”, which is the reluctance or postponement of receiving vaccinations, even in the presence of immunization services.6 There are several reasons for this, such as socioeconomic or religious beliefs, a lack of confidence in the healthcare system, worries about the safety of the vaccines, and their possible relation to the development of other diseases like autism.7–9 It is believed that concerns regarding vaccinations are one of the primary reasons for their underutilization. A prior study carried out in Jeddah, Saudi Arabia, found a link between vaccine hesitancy and parents’ awareness.10

    Due to the lack of awareness, many parents underestimate the danger of diseases while overestimating vaccine risks.8 A study conducted in Saudi Arabia by Alaamri et al found that 43% of participants expressed some concern about the safety of childhood vaccine doses, while another 43% were somewhat worried about the effectiveness of these doses in preventing diseases.11

    Even in cases with high vaccination coverage, assessing parental knowledge and attitude about vaccinations is greatly important, as they affect their children’s vaccination status. The presence of any parental misconceptions or uncertainties may represent a possible future obstacle to obtaining widespread vaccine adoption and adherence. Also, this can be considered as a part of proactive action by authorities, tailoring long-term interventions to improve the uptake, maintain the high vaccination coverage, and prevent outbreaks.12 Many studies in Saudi Arabia explored knowledge, attitudes, and practices regarding childhood vaccination among parents, but showed a wide discrepancy in results between different regions. To the best of our knowledge, this is the first study in Tabuk City, Saudi Arabia, to determine parental knowledge and attitude about childhood vaccination as well as address their perceived barriers to vaccination.

    Materials and Methods

    Study Design and Setting

    The study was cross-sectional and took place in Tabuk, Saudi Arabia, over three months, from the end of December 2024 to the end of March 2025.

    Participants

    Sample Size Calculation

    It was calculated by the OpenEpi online calculator, version 3, based on a 95% confidence interval, 80% power, and a prior study by Alshammari et al (2021)7 in Riyadh, KSA, which indicated that 73.3% of the parents knew a lot about childhood vaccinations. The estimated sample size was 301 parents, and 10% was added for failure to respond; hence, there will be 330 parents in all.

    Sampling Technique

    In order to satisfy the participation requirements, a convenience sample was obtained from the parents who went to various primary healthcare facilities to vaccinate their children.

    Inclusion and Exclusion Criteria

    The eligible participants were the parents who attended several primary healthcare facilities to vaccinate their children and had at least one kid, were willing to give their informed consent to participate in the study, or could read, comprehend, and complete the study survey in Arabic. Those who do not live in the designated geographic area (Tabuk City) or who are not the children’s primary guardians (such as neighbors or family) will be excluded.

    Research Tools

    After receiving permission to use the valid questionnaire from a prior study of a similar nature,7 it was given to the participants. It had a Cronbach alpha greater than 0.7 for the knowledge and attitude scores. The first section of the questionnaire assessed the parents’ sociodemographic information, including their age, gender, place of residence, level of education, occupation, and number of children. It also collected data on the sources of their information about vaccinations, offering four options: from friends and family, social media, doctors, or attending a health session. Ten statements on a three-point Likert scale, with the choices being “I do not know”, “No”, and “Yes”, made up the second section, which assessed their understanding of childhood vaccinations. The code one was assigned to the right response and zero to the incorrect response. Then, the third segment was composed of 10 questions about the parents’ opinions on childhood immunizations using a five-point Likert scale ranging from strongly agree to disagree strongly. The median for knowledge and attitude total scores was used as the cutoff criterion to divide scores into inadequate knowledge or negative attitude (<50%) and adequate knowledge or positive attitude (≥50%). Lastly, yes/no questions about parents’ compliance with childhood vaccination and their perceived obstacles to vaccination were asked.

    Ethics Approval and Consent to Participate

    “All procedures carried out in studies involving human participants were following the 1964 Helsinki Declaration and its subsequent amendments or comparable ethical standards”. The University of Tabuk’s Local Research Ethics Committee (LREC) in Tabuk, Saudi Arabia, granted ethical approval for the study with reference number UT-486-265-2024. An anonymous questionnaire was used to collect data; each participant was asked for their informed consent on the first page of the questionnaire, which also included a description of the study’s goal and a confirmatory statement about the confidentiality of the data gathered.

    Statistical Analysis

    Statistical package for social sciences (SPSS) version 23.0 was used to analyze the data. The quantitative and qualitative variables were described using descriptive statistics by mean, standard deviation (SD), and percentages. The Chi-square test was used to examine the relationship between parents’ sociodemographic (the independent factors) and their knowledge and attitude scores (dependent variables). When cells with expected value less than 5, Fisher’s exact probability test was applied. To determine the factors associated with parents’ knowledge and attitudes on vaccinations, multiple binary logistic regression was conducted with the “enter” method, as a model selection technique. The relationship between attitude and total knowledge scores was examined using the Pearson correlation coefficient. A p-value of less than 0.05 was regarded as statistically significant.

    Results

    Three hundred and thirty parents were included in this study. Their age ranged from 20 to 60 years old, with 79.7% of them being between 30 and less than 50 years old. 80.3% were mothers, and 94.5% lived in Tabuk City. Regarding the educational level, the majority (73.9%) were at the university level. 42.4% of the studied parents had more than three children. 89.4% of them worked in occupations not related to the health sector. Most of them (71.2%) received information about childhood vaccination from family and friends, while others learned from doctors or attended health sessions or social media (14.2%, 9.7%, or 4.8%, respectively) [Table 1].

    Table 1 The Relationship Between Knowledge Score Categories and Sociodemographic Characteristics of the Studied Parents in Tabuk, Saudi Arabia, 2024–2025

    Of the 330 parents who participated in the study, 218 (66.1%) had adequate knowledge about children’s vaccination when their scores were categorized using the median [Table 1].

    When compared to parents with inadequate information, the parents with acceptable knowledge were between the ages of 30 and 40 (56.9% versus 45.5%; P<0.05). On the other hand, fewer parents in the 20–30 age range had sufficient knowledge (11.0% versus 23.2%; P<0.05). Additionally, all illiterate parents had an inadequate level of knowledge, and 80.3% of those with adequate knowledge had a university education compared to 61.6% of those with inadequate knowledge. Compared to parents who did not work in the health sector, those who did had better adequate knowledge (13.3% versus 5.4%; P<0.05). In contrast to parents who had inadequate knowledge, the parents who knew enough about childhood vaccinations were more likely to get information from doctors and health sessions (17.9% and 11.9% versus 7.1% and 5.4%, respectively) than from friends and family (64.2% versus 84.8%, P<0.05) [Table 1].

    By classifying the parents’ attitude scores using the median, the study revealed that 183 (55.5%) of the 330 parents had a positive attitude [Table 2].

    Table 2 The Relationship Between Attitude Score Categories and Sociodemographic Characteristics of the Studied Parents in Tabuk, Saudi Arabia, 2024–2025

    Parents who had a positive attitude were more likely to be between the ages of 30 and 40 than parents who had a negative attitude (60.1% versus 44.2%; P<0.05), and fewer were older than 50 (3.8% versus 6.8%; P<0.05). While 82.0% of parents with a positive attitude had a university degree, 63.9% of parents with a negative attitude had this degree (P<0.05). Parents who worked in the medical field showed more positive attitudes than those who had negative attitudes (15.8% compared to 4.1%; P<0.05), as did parents who learned about children’s vaccinations from medical professionals and health sessions (20.2% and 16.4% versus 6.8% and 1.4%, respectively). On the other hand, more people with negative attitudes got their knowledge from friends and family than those with positive attitudes (86.4% versus 59.0%, P<0.05) [Table 2].

    In terms of binary logistic regression, those between the ages of 30 and <40 and 40 and <50 had considerably higher adequate knowledge, with 2.6 (OR with 95% CI: 2.6 with 1.3–5, P<0.05) and 2.3 (OR with 95% CI: 2.3 with 1.1–4.7, P<0.05) years, respectively. University-educated parents were twice as knowledgeable (OR with 95% CI: 2.1 with 1.6–2.8, P<0.05), and those who worked in the medical field were 2.7 times more knowledgeable (OR with 95% CI: 2.7 with 1.1–6.7, P<0.05). However, those between the ages of 30 and under 40 (OR with 95% CI: 2.3 with 1.2–4.4, P<0.05) and those with a university education (OR with 95% CI: 1.7 with 1.3–2.3, P<0.05) exhibited a statistically significant positive attitude and were about twice as positive as others. The positive attitude of those working in the medical field was four times higher than that of those in other occupations (OR with 95% CI: 4.4 with 1.7–10.9, P<0.05). Additionally, parents who received information about vaccinations from doctors were 15 times more likely to have a positive attitude (OR with 95% CI: 15 with 2.6–85, P<0.05) and from health sessions approximately four times (OR with 95% CI: 3.7 with 1.1–12.3, P<0.05) [Table 3].

    Table 3 Multiple Binary Logistic Regression to Detect Associated Factors of Good Knowledge and Attitude Scores Among the Studied Parents in Tabuk, Saudi Arabia, 2024–2025

    In this research, the higher the level of knowledge score among the studied parents, the greater their attitude score (r = 0.603, P < 0.05) [Table 4].

    Table 4 The Correlation Between Knowledge and Attitude Scores of the Studied Parents in Tabuk, Saudi Arabia, 2024–2025

    The percentage of participants who complied with the immunization schedule was 62.9% [Figure 1a]. Their perceived obstacles to immunization were the child’s illness (32.8%), a family member’s sickness (36.7%), being occupied on the day of vaccination (31.4%), fear regarding the side effects of the vaccine (21.9%), or being unaware of the next dose (6.8%) [Figure 1b].

    Figure 1 The compliance with childhood vaccination and the perceived barriers to vaccination among the studied parents in Tabuk, Saudi Arabia, 2024–2025.

    Discussion

    As a cost-effective intervention for promoting children’s health, vaccination has been recognized as one of the most significant public health accomplishments, lowering morbidity and mortality from related vaccine-preventable diseases.13 Increasing the vaccine coverage rate and parents’ adherence to the vaccination schedule depends heavily on parental awareness and attitude toward childhood vaccinations, which will be reflected in the long-term incidence and prevalence of major childhood infectious diseases.12 The purpose of this study was to ascertain the knowledge and attitudes of parents in Tabuk, Saudi Arabia, about childhood vaccinations as well as address their perceived barriers to vaccination.

    The current study’s findings indicate that 66% of participants knew adequately about vaccinations for their children. The results are greater than those of research in Indonesia,14 where only roughly half of the participants had adequate knowledge, but they are nearly consistent with similar studies carried out in Malaysia,15 Cyprus,16 Rwanda,17 and Saudi Arabia.7,10,11,18 Even though we would prefer to find higher levels of parental knowledge, the reported medium-degree level of knowledge is more important and preferable than being unaware of the health advantages of vaccinations in preventing infectious diseases in children, which is linked to low vaccination coverage rates.19 Also, the study’s findings are an important reflection of the policies and practices that Saudi Arabia’s Ministry of Health has put in place concerning the country’s immunization program in recent years.

    It’s documented that children’s immunization status is significantly impacted by parents’ attitudes.20 The results of this study showed that slightly more than half of the participants had a positive attitude. This acceptable attitude is thought to be a reflection of the level of adequate knowledge. This is consistent with other comparable investigations.7,21,22

    Parents’ attitudes toward vaccinating their children and their level of knowledge were found to be significantly positively correlated in this study. It demonstrates that the commitment to getting their children vaccinated increases with their level of knowledge. A research study in Malaysia reported a similar finding.15

    The participating parents, who were middle-aged, had significantly adequate knowledge and positive attitudes toward vaccination. This is similar to a study conducted in Saudi Arabia,7 while contradictory to the study conducted in Malaysia,15 which found parents with younger age groups had higher knowledge and better attitudes. The difference between the studies’ results may be due to differences in the characteristics of the participants as well as the abundance of vaccination centers and easy and free access to vaccination services in Saudi Arabia.

    It was proposed that mothers’ academic standing had a major impact on their decisions to vaccinate their children.15 As demonstrated by the current study, the majority of parents with higher levels of knowledge and attitude held a university degree. This is consistent with previous similar studies carried out in Rwanda,17 Saudi Arabia,18 and Malaysia,21 but it differs from another study conducted in Malaysia that discovered no significant association between parents’ educational backgrounds and the decision to vaccinate their children.23 This might be because parents with higher education levels are more likely than parents with lower education levels to be health literate, to recognize, understand, and apply health-related information, and to recognize the importance of children’s vaccinations and appropriate medical procedures.24

    Parents who worked in occupations related to the healthcare sector had significantly higher levels of adequate knowledge and positive attitudes regarding vaccination compared to those who did not work in healthcare. This is comparable to an investigation conducted in Malaysia, in which the medical professionals’ opinions and attitudes toward vaccines were more favorable than non-healthcare professionals.21 The present finding is important, as healthcare workers are the key to the success of the healthcare system in improving population health in any community; if they have inaccurate knowledge about vaccinations, this can lead to vaccine hesitancy and a negative attitude toward vaccinations among the public.25–27

    Our findings reflect the assumption that parents’ knowledge and subsequent attitude and behavior are primarily based on the proficiency of medical professionals who recommend and advise the immunizations.28 The majority of parents with higher levels of knowledge and attitudes significantly get their trusted information on vaccinations from their children’s doctors and health personnel and health sessions, emphasizing the healthcare providers’ ability to influence parental knowledge and choices and reassure them about the safety of vaccines. Our results are in line with those of several earlier investigations.16,29,30 These highlight how important doctors are in providing up-to-date, evidence-based vaccine information and helping parents decide whether to vaccinate their children.

    A prior study in Jordan found that mothers who got their immunization information from medical personnel knew more about vaccinations than mothers who got their information from other sources, such as websites, mass media, friends, and family. Other sources can provide inaccurate information, which will create a negative attitude and eventually result in the underutilization of vaccinations.31

    More than half of the parents who took part in the study were complied to the vaccine schedule, which is consistent with other studies.32,33 Nonetheless, the Ministry of Health’s contribution is clear in the fact that childhood vaccinations are accessible without requiring payment or transportation. There were still some instances of non-compliance brought on by a lack of awareness or a negative attitude, such as not knowing the timetable or being afraid of its negative effects. This is consistent with another study conducted in Saudi Arabia by Bin Alamir (2024), who discovered that the main obstacle to vaccination compliance was vaccine hesitancy.34 The same findings were seen in other studies conducted in Iraq32 and India,33 but there were other explanations, such as vaccination unavailability, travel difficulties, or budgetary constraints.

    Strengths and Limitations

    This study is, as far as we are aware, the first research that provides insightful information about parents’ awareness and attitude toward childhood vaccinations in Tabuk, Saudi Arabia, and their perceived vaccination barriers, which can guide future investigations and programs. However, some limitations were recognized; since this study was cross-sectional, it’s difficult to conclude the causal relationships between various underlying factors and parents’ knowledge or attitudes. Additionally, selection bias may cause the odds ratio (OR) to not accurately reflect the true prevalence ratio (PR). Multivariate analysis, which is used to control for confounding, was attempted to be used to overcome this and assist in minimizing these constraints by adjusting for potential confounders. Among the limitations of this study is that the results cannot be generalized to all Saudi Arabian parents because of the convenience sampling method and the fact that it was conducted in just one Saudi Arabian city.

    Practical Implications

    There are numerous significant implications of this study. Ministry of Health and policymakers should create a vaccination communication plan targeting parents who exhibit low knowledge attitude levels reflected in their practice regarding vaccine utilization, considering the factors that contribute to these situations, to maintain and increase the immunization rate. Open communication between physicians and parents will help to raise understanding about vaccine safety and the significance of immunization by eliminating vaccine myths and rumors, clearing up false information, and scientifically addressing vaccine safety concerns. Such approaches aim to build confidence in children’s vaccination. The Ministry of Health requires new, more advanced communication methods, such as social media and social marketing technologies, and an internet channel could be initiated to be used by nurses and other medical professionals to spread accurate information and emphasize the advantages of vaccination on the national level.

    Conclusions

    More than half of the parents in the study had favorable attitudes and sufficient knowledge about children’s vaccinations. These parents were middle-aged, university-educated, had occupations in the health sector, and primarily relied on doctors for information. The most common vaccine barriers among the parents surveyed were being busy on the day of the vaccination and a family member’s illness.

    To ascertain the relationship between parental attitudes and knowledge and children’s immunization behavior, more studies are necessary. Additionally, it is recommended that further longitudinal studies be performed to prove the predictors of parents’ knowledge and attitudes regarding children’s vaccinations. Myths and false information about vaccines can be dispelled by collaboration between doctors, parents, public health experts, governments, and civil society. It is essential to promote awareness initiatives that highlight the importance, efficacy, and safety of childhood vaccinations.

    Data Sharing Statement

    Available from the corresponding author upon request.

    Acknowledgments

    We extend our gratitude to Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R90), Princess Nourah Abdulrahman University, Riyadh, Saudi Arabia. Also, a heartfelt thanks to the parents who took the time to offer their precious perspective.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Funding

    This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project number (PNURSP2025R90), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

    Disclosure

    The authors declare no conflict of interest.

    References

    1. Vassiliki P, Ioanna K, Artemis V, et al. Determinants of vaccination coverage and adherence to the Greek national immunization program among infants aged 2-24 months at the beginning of the economic crisis (2009-2011). BMC Public Health. 2014;14:1192. doi:10.1186/1471-2458-14-1192

    2. World Health Organization (WHO). Vaccines and immunization. Available from: https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1. Accessed February 22, 2025.

    3. Al-Nafeesah AS, Aldamigh AS, Almansoor BA, Al-Wutayd O, AlE’ed AA. The impact of the COVID-19 pandemic on parents’ behavior toward scheduled pediatric vaccinations in Saudi Arabia. Infect Dev Ctries. 2021;15(8):1054–1058. doi:10.3855/jidc.13765

    4. Alsubaie SS, Gosadi IM, Alsaadi BM, et al. Vaccine hesitancy among Saudi parents and its determinants. Result from the WHO SAGE working group on vaccine hesitancy survey tool. Saudi Med J. 2019;40(12):1242–1250. doi:10.15537/smj.2019.12.24653

    5. Shaw J, Mader EM, Bennett BE, Vernyi-Kellogg OK, Yang YT, Morley CP. Immunization mandates, vaccination coverage, and exemption rates in the United States. Open Forum Infect Dis. 2018;5(6):ofy130. doi:10.1093/ofid/ofy130

    6. Alamer F, Alamir A, AlJohani S, et al. Childhood vaccination hesitancy in Saudi Arabia: a time for action. J Infect Public Health. 2022;15(1):94–99. doi:10.1016/j.jiph.2021.11.009

    7. Alshammari SZ, AlFayyad I, Altannir Y, Al-Tannir M. Parental awareness and attitude about childhood immunization in riyadh, saudi arabia: a cross-sectional study. Int J Environ Res Public Health. 2021;18(16):8455. doi:10.3390/ijerph18168455

    8. Oldfield BJ, Stewart RW. Common misconceptions, advancements, and updates in pediatric vaccination administration. South Med J. 2016;109(1):38–41. doi:10.14423/SMJ.0000000000000399

    9. Koslap-Petraco M. Vaccine hesitancy: not a new phenomenon, but a new threat. J Am Assoc Nurse Pract. 2019;31(11):624–626. doi:10.1097/JXX.0000000000000342

    10. Alghamdi AA, Alghamdi HA. Knowledge, attitude, and practice of vaccination among parents in Jeddah City, Saudi Arabia. Cureus. 2023;15(7):e41721. doi:10.7759/cureus.41721

    11. Alaamri O, Okmi EA, Suliman Y. Vaccine hesitancy in Saudi Arabia: a cross-sectional study. Trop Med Infect Dis. 2022;7(4):60. doi:10.3390/tropicalmed7040060

    12. Santos CA, Costa RD, Silva JL, Santos MD, Gomes BL. Conhecimento, atitude e prática dos vacinadores sobre vacinação infantil em Teresina-PI, 2015 [Knowledge, attitude and practice on childhood immunization personnel in Teresina-PI, Brazil, 2015]. Epidemiol Serv Saude. 2017;26(1):133–140. doi:10.5123/S1679-49742017000100014

    13. Bedford H, Elliman D. Concerns about immunisation. BMJ. 2000;320(7229):240–243. doi:10.1136/bmj.320.7229.240

    14. Elbert B, Zainumi CM, Pujiastuti RAD, et al. Mothers’ knowledge, attitude, and behavior regarding child immunization, and the association with child immunization status in Medan City during the COVID-19 pandemic. IJID Reg. 2023;8:S22–6. doi:10.1016/j.ijregi.2023.03.014

    15. Makhdzir N, Rashid A, Pien LS, Zaini NH. Mothers’ knowledge on immunization and the commitment to get their child immunized in a Suburban Region of Selangor, Malaysia. Int J Care Scholars. 2024;7:76–84. doi:10.31436/ijcs.v7i3.375

    16. Kyprianidou M, Tzira E, Galanis P, Giannakou K. Knowledge of mothers regarding children’s vaccinations in Cyprus: a cross-sectional study. PLoS One. 2021;16(9):e0257590. doi:10.1371/journal.pone.0257590

    17. Mbonigaba E, Yu F, Reñosa MDC, et al. Knowledge and trust of mothers regarding childhood vaccination in Rwanda. BMC Public Health. 2024;24(1):1067. doi:10.1186/s12889-024-18547-1

    18. Almutairi WM, Alsharif F, Khamis F, et al. Assessment of mothers’ knowledge, attitudes, and practices regarding childhood vaccination during the first five years of life in Saudi Arabia. Nurs Rep. 2021;11(3):506–516. doi:10.3390/nursrep11030047

    19. Balbir Singh HK, Badgujar VB, Yahaya RS, et al. Assessment of knowledge and attitude among postnatal mothers towards childhood vaccination in Malaysia. Hum Vaccin Immunother. 2019;15(11):2544–2551. doi:10.1080/21645515.2019.1612666

    20. Dyda A, King C, Dey A, Leask J, Dunn AG. A systematic review of studies that measure parental vaccine attitudes and beliefs in childhood vaccination. BMC Public Health. 2020;20(1):1253. doi:10.1186/s12889-020-09327-8

    21. Mukhtar AF, Abdul Kadir A, Mohd Noor N, Mohammad AH. Knowledge and attitude on childhood vaccination among healthcare workers in hospital Universiti Sains Malaysia. Vaccines. 2022;10(7):1017. doi:10.3390/vaccines10071017

    22. Kumar P, Kavinprasad MA. study to assess the parent’s knowledge and attitudes on childhood immunization. Int J Commun Med Public Health. 2018;5:4845. doi:10.18203/2394-6040.ijcmph20184582

    23. Ahmad NA, Jahis R, Kuay LK, Jamaluddin R, Aris T. Primary Immunization among children in Malaysia: reasons for incomplete vaccination. J Vaccines Vaccin. 2017;8:358. doi:10.4172/2157-7560.1000358

    24. Csima M, Podráczky J, Keresztes V, Soós E, Fináncz J. The role of parental health literacy in establishing health-promoting habits in early childhood. Children. 2024;11(5):576. doi:10.3390/children11050576

    25. Verger P, Fressard L, Collange F, et al. Vaccine hesitancy among general practitioners and its determinants during controversies: a national cross-sectional survey in France. EBioMedicine. 2015;2(8):891–897. doi:10.1016/j.ebiom.2015.06.018

    26. Karafillakis E, Dinca I, Apfel F, et al. Vaccine hesitancy among healthcare workers in Europe: a qualitative study. Vaccine. 2016;34(41):5013–5020. doi:10.1016/j.vaccine.2016.08.029

    27. Elizondo-Alzola U, Carrasco G, Pinós M, L PCA, Rius C, Diez E. Vaccine hesitancy among paediatric nurses: prevalence and associated factors. PLoS One. 2021;16(5):e0251735. doi:10.1371/journal.pone.0251735

    28. Larson Williams A, Mitrovich R, Mwananyanda L, Gill C. Maternal vaccine knowledge in low- and middle-income countries-and why it matters. Hum Vaccin Immunother. 2019;15(2):283–286. doi:10.1080/21645515.2018.1526589

    29. Gellin BG, Maibach EW, Marcuse EK. Do parents understand immunizations? A national telephone survey. Pediatrics. 2000;106:1097–1102. doi:10.1542/peds.106.5.1097

    30. Šeškutė M, Tamulevičienė E, Levinienė G. Knowledge and attitudes of postpartum mothers towards immunization of their children in a Lithuanian tertiary teaching hospital. Medicina. 2018;54(1):2. doi:10.3390/medicina54010002

    31. Masadeh MM, Alzoubi KH, Al-Azzam SI, Al-Agedi HS, Abu Rashid BE, Mukattash TL. Public awareness regarding children vaccination in Jordan. Hum Vaccin Immunother. 2014;10(6):1762–1766. doi:10.4161/hv.28608

    32. Abdullah S, Mustafa I. Knowledge and attitude of mothers about children immunization and barriers to adherence the program, in Erbil City. Erbil J Nurs Midwifery. 2022;5(1):51–60. doi:10.15218/ejnm.2022.06

    33. Jelly P, Jeenwal N, Kumari N, et al. Knowledge, attitude, compliance and barriers of immunization among Parents’ of under-five children. Int J Africa Nurs Sci. 2023;19:100608. doi:10.1016/j.ijans.2023.100608

    34. Bin Alamir AA. Childhood vaccination hesitancy in Saudi Arabia: are we still facing a problem? Saudi Med J. 2024;45(6):551–559. doi:10.15537/smj.2024.45.6.2024011

    Continue Reading

  • Villages marooned after deadly floods in India’s Punjab

    Villages marooned after deadly floods in India’s Punjab


    HANOI: Crispy banh mi baguettes, grand colonial facades, and chattering Francophone schoolchildren are lingering reminders of the French presence that once dominated Vietnam.

    But there are darker legacies too — in the notorious prisons that enforced foreign rule, and memorials to those slain fighting for independence.

    As Vietnam marked the 80th anniversary of the declaration of independence from its European ruler with a grand parade on Tuesday, 24-year-old Huynh Nhung came to the capital, Hanoi, to take it all in.

    “There are both good and bad sides,” she told AFP, touring Hoa Lo Prison — now a memorial partly dedicated to France’s brutal treatment of Vietnamese colonial dissidents.

    “France left a lot of pain for the country,” she said, a few days before the event.

    But when 40,000 soldiers and civilians begin marching, her thoughts will turn away from France’s “story of the past” and toward Vietnam’s eight decades of self-definition.

    “Vietnam doesn’t need to cling to another country or rely on another power to lead the nation,” she said.

    French Indochina was officially established in 1887 and eventually encompassed all of modern-day Vietnam, as well as neighboring Cambodia and Laos.

    A communist insurgency led by Ho Chi Minh ousted the colonial administration and declared independence on September 2, 1945.

    Some French influence remains woven into the fabric of Vietnam’s daily life.

    Banh mi — a delicacy fusing the imported French baguette with local Asian meat and vegetable fillings — is one of the nation’s most popular day snacks.

    But 43-year-old Nguyen Thi Van, hawking the sandwiches in Hanoi’s “French Quarter,” said she “never really thought about the origins” of the cuisine.

    “It’s just always been there since my childhood,” she shrugged.

    The capital’s streets, lined with colonial mansions that once housed French administrators, are now festooned with the red flags of independent communist Vietnam.

    When soldiers goose-step down them, Carlyle Thayer — Emeritus Professor at Australia’s University of New South Wales — anticipates little thought will be spared for France.

    “I expect Vietnam’s leaders will express pride in Vietnam’s achievements over the last eight decades,” he told AFP, predicting “minimal reference to French colonialism.”

    There are still pockets of French influence in Vietnam, enough to tantalize some schoolchildren into imagining a Francophone future.

    Enrolled in French language classes, 10-year-old Linh Anh said she dreams of being a French teacher. Her classmate Ngoc Anh wants to be an architect “like Monsieur Eiffel.”

    Of Vietnam’s 100 million people, around 650,000 still speak French — mostly those who lived through the end of the colonial era or were born shortly after independence.

    And around 30,000 schoolchildren study the language, according to official figures.

    Hanoi’s Doan Thi Diem School was the first in the capital to introduce French at primary level.

    “French is a language of culture and diplomacy,” 28-year-old teacher Luu Thanh Hang told AFP.

    “It helps students, children, develop their critical thinking and their creativity.”

    But the language may be more a marker of cultural prestige than an economic asset, with few Francophone jobs in Vietnam and little migration to France.

    During his visit in May, French President Emmanuel Macron inked billion-euro contracts and presented his country as a “sure and reliable friend.”

    But Vietnam has proven more interested in “bamboo diplomacy” — a flexible approach aiming to steer good relations with all comers, including superpowers the United States and China.

    On the streets of Hanoi, spectators gathered for the parade set to celebrate Vietnam above all else.

    “Everyone who comes here shares that patriotic spirit,” said 20-year-old Vu Thi Ngoc Linh, running a photo booth where attendees posed for souvenir snaps.

    “I feel that every customer feels very proud to be a child of Vietnam.”

    Continue Reading